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The literature on the interaction effects of explanatory variables on properties of 
injectable bone cements used in the vertebral augmentation procedures of vertebroplasty 
and balloon kyphoplasty is sparse. In the present work, response surface methodology 
was used to investigate the direct and interaction effects of variables on three properties 
of a poly (methyl methacrylate) bone cement (maximum exotherm temperature, residual 
monomer content (RMC), and degradability) and three properties of a calcium phosphate 
cement (CPC) (injectability, final setting time (F), and compressive strength). Some main 
findings were 1) interaction effects were statistically significant for some properties, such 
as F, but not for others, such as RMC; and 2) values of variables that led to optimum or 
minimum cement properties; for example, optimum injectability of a CPC (98%) could 
be attained using a cement with a poly(ethylene glycol) content of 20 wt/wt% and 
prepared using a powder-to-liquid ratio of 2.0 g mL
-1
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   CHAPTER 1 
INTRODUCTION 
Osteoporosis is a serious and potentially life-threatening disease. It is postulated 
to be one of the main causes of an increase in the fragility of bone and an 
accompanying decrease in its strength [1]. Thus, the consequence of osteoporosis is 
an increase in susceptibility to fracture of bones, particularly vertebral bodies in the 
mid-thoracic, lower-thoracic, and higher-lumbar levels of the spine [2]. There is a 
high incidence of these spinal fractures, usually referred to as vertebral compression 
fractures (VCFs) [3]. The impact of VCF(s) on patient quality of life can be 
substantial, resulting in pain and deformity, which limit mobility and adversely affect 
ability to perform activities of daily living [4].  
Treatment of VCF(s) includes conservative (non-surgical) and surgical methods. 
Examples of conservative treatments are bed rest, analgesia for pain, and bracing for 
support [5]. Surgery is used when conservative treatment(s) fail to provide adequate 
pain relief. Current surgical practice involves use of a minimally invasive procedure, 
namely, vertebroplasty (VP) or balloon kyphoplasty (BKP) [6]. 
In VP, the surgeon utilizes fluoroscopy to visually guide a needle through the 
pedicle of the collapsed vertebral body (VB) bilaterally and inject a bolus of an 
injectable bone cement (IBC) to strengthen and stabilize the fractured bone. The 
cement typically hardens within minutes. VP helps in relieving pain by providing 
mechanical support and stability to the collapsed VB [7]. BKP begins with the 
placement of a cannula on the VB and then, using a transpedicular or parapedicular 
approach and guided by fluoroscopy, a tube is inserted into the center of the VB to 
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the site of the fracture, and a balloon tamp is introduced through the tube into the 
space and inflated. After that, the balloon is deflated and removed and the resulting 
cavity that is formed is filled with a bolus of an IBC, which hardens within minutes, 
stabilizing the VB [8]. 
A key variable that affects the outcome of either VP or BKP is the type of IBC 
used. The IBCs that are widely used in these procedures are PMMA bone cement and 
calcium phosphate cement (CPC), each of which has its attractive features and 
shortcomings [9]. A PMMA bone cement is biocompatible and bioinert, is easy to 
handle, has adequate mechanical strength, is reasonably priced, and is very familiar to 
spine surgeons and interventional radiologists. However, a PMMA bone cement does 
not allow for direct apposition of new bone, lacks the potential to remodel and/or 
integrate with the adjacent bone, and, usually, is encapsulated by a thin fibrous layer 
after implantation. Other shortcomings of PMMA bone cement are a high 
polymerization (exothermic) temperature and the potential for monomer toxicity. A 
CPC is nontoxic, resorbs gradually and is replaced by new host bone via creeping 
substitution, cures via an endothermic reaction, and does not cause tissue necrosis 
and/or neural injury secondary to curing. However, the biomechanical properties of a 
CPC in a load-bearing situation are of concern; for example, its compressive strength 
is substantially lower than that of a PMMA bone cement. Other shortcomings of a 
CPC compared to PMMA bone cement include its lower viscosity, shorter setting 
time, lower injectability, lower radiopacity, and higher cost. 
There are a host of literature reports on the direct effects of many relevant 
variables on various properties of PMMA bone cements and CPCs [10]. In contrast, 
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there are very few reports on interactive effects of two or more variables on the 
properties of either of these types of cements [11]. The purpose of the present study 
was to investigate the direct and interactive effects of a number of variables on 
different properties of a PMMA bone cements and of a CPC, leading to the 
computation of the values of the variables that yield the optimum value for a given 
cement property. The cement properties considered in the present study  are a sample 
of ones that need to be improved; namely, maximum exothermic temperature, 
residual monomer content, and degradability in the case of a PMMA bone cement and 
injectability, setting time, and compressive strength in the case of a CPC. The 
investigations were carried out using response surface methodology (RSM) [12].  
The thesis is organized into five chapters. Key aspects of all the background 
topics relevant to the study are presented in Chapter 2. These topics are anatomy and 
functions of the spine, osteoporosis, VCFs, VP and BKP, PMMA bone cements, 
CPCs, design of experiments, and RSM. Reviews of the literature on the influence of 
variables on properties of PMMA bone cements used in or proposed for use in VP 
and BKP, influence of variables on the properties of CPCs, and applications of RSM 
to PMMA bone cements and CPCs are presented in Chapter 3. Details of six case 
studies, in which RSM was used to determine the optimum value of a cement 
property, are given in Chapter 4. In each case study, the format comprises a 
description of the experimental method used to determine the cement property; the 
collection of the property results, as a function of the variables considered; the results 
of the RSM work; and a discussion of the RSM findings. The final chapter in the 
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thesis, Chapter 5, contains a statement of the study conclusions and recommendations 

























2.1.    The spine 
2.1.1.   Anatomy of the spine  
The spine, which consists of 33 individual vertebrae (bony members) (Fig. 1), is an 
inverted S-shaped curve, with the top part being convex and called the cervical region 
(C1-C7), the middle part being concave and called the thoracic region (T1-T12), and the 
bottom part being convex and called the lumbar region (L1-L5) [13]. Only the top 24 of 
these vertebrae are moveable because ligaments and muscles connect them. Distal to the 
lumbar region are the sacrum (five fused bones) and the coccyx (four fused bones).   
   
 
Fig. 1.         The five regions of the spinal column [13]. 
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Each moveable vertebra (Fig. 2) has three functional parts: a drum-shaped body 
(vertebral body (VB)), which has a broad transverse surface area and, as such, is designed 
to bear weight and withstand applied compression loads (shown as purple); an arch-
shaped bone that protects the spinal cord (shown as green); and star-shaped processes 
designed as outriggers for muscle attachment (shown as tan). 
 
 
Fig. 2.  The three main parts of a vertebra [13]. 
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In each spinal region, the vertebrae have unique features that help them perform 
various functions. The cervical vertebrae support the weight of the head (~ 45 N). The 
neck has the greatest range of motion because of two specialized cervical vertebrae that 
connect to the skull. The first of these (C1), called the atlas, connects directly to the skull 
and allows for the nodding or “yes” motion of the head, while the other (C2), called the 
axis, allows for the side-to-side or “no” motion of the head. The thoracic vertebrae hold 
the rib cage and protect the heart and the lungs. The range of motion in the thoracic spine 
is limited. The lumbar spine bears the weight of the body and service loads. Thus, the 
lumbar vertebrae are larger than those in the cervical and thoracic regions. The main 
function of the sacrum is to connect the spine to the hip bones (iliac bones). The sacrum 
and the iliac bones form a ring called the pelvic girdle. The bones of the coccyx or 
tailbone provide attachment for the ligaments and the muscles of the pelvic floor. 
Each pair of moveable vertebrae is separated by an intervertebral disc (IVD), which 
consists of two main parts, namely, the annulus fibrosus and the nucleus pulposus (Fig. 
2). The annulus is comprised of criss-crossing fibers that pull against the outward force of 
the nucleus to hold the shape of the disc. The nucleus is filled with a fluid (an 
incompressible gel) that provides elastic resistance between the vertebrae. The fluid is 







2.1.2.  Functions of the spine 
The spine performs a number of functions: it provides support for the body, acts as 
the body’s shock absorber, helps the body to remain balanced, gives flexibility to the 
body (thereby allowing motions of extension, flexion, left lateral bending, right lateral 
bending, clockwise-acting axial torsion, and counterclockwise-acting axial rotation), and 
protects the spinal cord [13].  
2.2.  Osteoporosis 
Osteoporosis, which is the most prevalent bone disease, is defined as a systematic 
skeletal disease characterized by low bone mass and disruption or deterioration of the 
microarchitecture of bone tissue (thinning of the bone), culminating in an increase of the 
fragility of the bone (decrease in bone strength) [14-16]. Thus, osteoporosis increases 
susceptibility to fracture of bones, particularly in the spine (vertebral bodies in the mid-
thoracic, lower-thoracic, and higher-lumbar levels), pelvis, wrist, humerus, and wrist. In 
more detail, the pathophysiology of osteoporosis is marked by an imbalance between 
bone production by osteoblasts and bone resorption by osteoclasts. In normal bone, there 
is a balance between these two processes, whereas, in osteoporotic bone, there is an 
increase in osteoclastic bone resorption due to an overall decrease in osteoblastic bone 
production and/or a direct increase in bone resorption [17, 18]. Among the risk factors for 
osteoporosis are age > 45 years, gender (being female), low body weight, smoking, and 
use of certain medications, such as oral glucocorticoids, anti-clotting drugs like heparin, 
cyclosporine drugs that treat immune system disorders, and drugs used to treat prostate 
cancer [19]. Dual-energy x-ray absorptiometry (DEXA) is the most widely used clinical 
method of screening for osteoporosis. A diagnosis of osteoporosis is given when a 
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person’s bone mineral density (BMD), measured using DEXA, is at least 2.5 standard 
deviations below the mean value for a “young normal” adult population of the same 
gender [19-21]. Other osteoporosis diagnostic methods, such as calcaneal quantitative 
ultrasound, quantitative computer tomography, and use of biochemical markers (urine 
and serum), are also available but, at the moment, are not widely used in the clinical 
setting [19-21].  
There are no symptoms of osteoporosis until bone fracture(s) occur. Thus, prevention 
is very important. This may involve, for example, lifestyle choices, such as not smoking 
and exercising on a frequent basis, and increasing calcium and/or vitamin D intake. 
When, however, a diagnosis of osteoporosis is given, treatment methods include use of 
pharmacotherapies (such as alendronate and calcitonin), muscle stretching, and ingestion 
of a dietary supplement [16, 19]. 
Osteoporosis is a major public health issue everywhere in the world but, particularly, 
in developed nations. For example, in the United States, it was reported that, in 2005, 
more than 2 million people suffered fractures related to osteoporosis and the direct cost 
associated with treating these fractures was about $22 billion [14]. With the graying of 
the population, both incidence and cost of treatment are expected to rise sharply, with one 
estimate of the rate of rise between 2005 and 2025 being 50% from its 2005 level [14]. 
2..3  Osteoporosis-induced vertebral body compression fractures 
In the adult spine, the cancellous bone in the VB carries the majority (55%) of the 
applied axial compressive loads [22]. The compressive strength of cancellous bone is 
directly proportional to the squared of its density () [22-24]. With osteoporosis, there is 
a marked decrease in ; as such, there is a high incidence of compression fractures of 
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VBs, usually referred to as vertebral compression fractures (VCFs), in osteoporotic 
patients. Since the thoracic and thoracolumbar regions of the spine have a natural 
kyphotic curvature, VBs in these regions are the most common sites of VCFs [25]. In the 
United States, there are 700,000 VCFs every year, with hospitalization for about 115,000     
cases [26]. 
2.4.   Percutaneous vertebroplasty and balloon kyphoplasty 
In cases where the pain due to VCFs is severe, persistent, and unresponsive to 
conservative treatments, such as medications, bed rest, wearing of back braces, and 
ingestion of narcotic analgesics, the only treatment option is surgical vertebral 
augmentation [27]. Such a procedure involves the percutaneous administration of a 
dough/paste of an injectable bone cement (IBC), usually a highly-radiopaque poly 
(methyl methacrylate) (PMMA) bone cement or a calcium phosphate cement (CPC), into 
the fractured VB, under fluoroscopic guidance [28,29]. The two variants of this technique 
in clinical use today are vertebroplasty (VP) and balloon kyphoplasty (BKP) [28-31].  
In VP, the fractured VB is accessed percutaneously with a high-caliber needle 
positioned using a transpedicular or paravertebral approach (Figs. 3 and 4) [29, 32-33]. 
Since VCFs are most commonly observed between the T8 and L2 levels, typically, about 
3-8 mL of the bone cement dough is injected directly into the collapsed/fractured VB(s) 
(Fig. 5). Once cured, the cement provides bone augmentation and stabilization, thereby 
preventing further collapse and movement. For VP, some of the critical factors that affect 
outcome are proper patient selection, correct needle placement, good timing of cement 
injection, and careful fluoroscopic control of injection of the cement dough/ paste [25, 26, 
33, 34]. Complications of VP include infections and cement leak into body tissues and 
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organs (a phenomenon known as cement extravasation). Some of the cement leaks have 
clinical importance; for example, epidural overflow of ABC may cause spinal cord 
compression; leaks into an IVD may increase the risk of fracture(s) of VB(s) adjacent to 
the one(s) being treated; and leaks into paravertebral veins can lead to pulmonary cement 
embolism [24,30,35]. However, other leaks, such as leaks into paravertebral soft tissues, 
do not have clinical significance [24, 30, 35].  
 
 






Fig. 4. A schematic drawing of a standard transpedicular puncture during vertebroplasty 
with a medial needle trajectory through the pedicle [29].  
 
 
Fig. 5.   Injection of cement through a needle into a fractured vertebral body [33].  
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There are five steps involved in BKP (Figures 6-8) [29, 30, 36-38]. First, a balloon-
like device (called a bone tamp) is placed in the fractured/collapsed VB, through a 
channel created by a drill in it. Second, a guide wire or biopsy needle is advanced into the 
VB, via a transpedicular or extrapedicular approach. Third, the bone tamp is inflated 
slowly until either the normal height of the VB is restored or the balloon reaches its 
maximum volume, whichever occurs first. Fourth, the bone tamp is deflated and 
removed, the cement is mixed (to yield a bolus), and the cement cannulae are prefilled, 
allowing the cement to partially cure in the cement cannulae. Fifth, the cement cannulae 
are positioned in the center of the cavity created by the bone tamp and then the bolus of 
the cement is slowly extruded into the cavity, under continuous lateral fluoroscopic 
guidance. This technique permits a low-pressure fill. One major challenge in BKP is that, 
because the cement is injected while it is highly viscous, the surgeon has to know the 
setting time of the cement before performing the treatment so that he/she would know 
when the cement is ready to be injected. One shortcoming of BKP is the pressure 
associated with inflation of the bone tamp is high enough to compact the cancellous bone 
around the tamp. One major risk of BKP is allergic reaction to the contrast agent used to 
visualize the bone tamp as it is being inflated. Complications of BKP include 
extravasation, pulmonary embolism, nerve root or spinal cord compression by the 




Fig. 6.   A schematic drawing of the bone tamp insertion step in balloon  






Fig. 7.   A schematic drawing of the steps of bone tamp removal, bone filler 
device insertion through a cannula, and cement injection into the cavity created in 














Fig. 8.  Schematic presentation of a summary of the main steps in balloon 
kyphoplasty [40]. 
 
There are three key differences and two similarities between VP and BKP in terms of 
clinical outcomes. The first difference is that the incidence of cement extravasation is 
significantly lower in BKP compared to VP (0-13.5% versus 2-67% of cases) [31, 37]. 
There are two reasons for this difference. One is that in BKP, the cement is injected into a 
cavity created in the fractured VB, rather than directly into the fractured VB as is done in 
VP. The other is that, in BKP, a very powerful plunger is used and the cement is injected 
while it is in a very viscous state, whereas, in VP, no plunger is used, and, so, the cement 
is injected while it is in a low-viscous state.  The second difference is that restoration of 
height of the treated VB(s) is significantly higher when BKP is used compared to VP is 
used (28% versus 96% of cases) [31, 41]. The third difference is that the incidence of 
adjacent-level fractures is markedly lower in BKP than in VP, a consequence of the 
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former method being more successful in restoring the overall spinal balance [41, 42]. The 
first similarity between VP and BKP is that there are many reports that the procedure is 
effective; that is, each leads to significant improvements in a patient’s functional abilities, 
enhanced performance of activities of daily living, and significant reduction in pain over 
the short- to medium-term [36]. The second similarity is that although, for each method, 
the mechanism of pain relief is not exactly known, it is believed to be achieved by way of 
two different actions: fracture stabilization as the cement hardens and heat necrosis of the 
nerve endings at the fracture site [41, 43].  
2.5.   Injectable bone cements for vertebroplasty and balloon kyphoplasty 
Two types of IBC are widely used for VP and BKP, namely, a PMMA cement that 
has a high amount of radiopacifier and a CPC [44]. A PMMA bone cement is 
biocompatible and bioinert, is easy to handle, has adequate mechanical strength, is 
reasonably priced, and is very familiar to spine surgeons and interventional radiologists. 
However, a PMMA bone cement does not allow for direct apposition of new bone, lacks 
the potential to remodel and/or integrate into adjacent bone, and, usually, is encapsulated 
by a thin fibrous layer after implantation. Other drawbacks of a PMMA bone cement are 
high polymerization temperature (which may lead to thermal necrosis of the 
periprosthetic tissue) and the potential for chemical necrosis of the periprosthetic tissue 
(which arises from toxicity of the residual monomer). A CPC is nontoxic and has the 
potential to resorb gradually and be replaced by new host bone via creeping substitution. 
Several animal studies have shown that a CPC is highly osteoconductive and, in vivo, 
undergoes gradual remodeling. In addition, curing of a CPC is an endothermic process 
and does not cause tissue necrosis and/or neural injury secondary to curing. However, the 
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mechanical properties of a CPC in a load-bearing situation are of concern because they 
are lower than those of a PMMA bone cement. Other shortcomings of a CPC include low 
viscosity (and, hence, low injectability), potential for separation of the solid phase from 
the liquid phase during extrusion of the paste through the syringe, limited radiopacity, 
and high cost [45].
 
2.5.1.   Poly (methyl methacrylate) (PMMA) bone cement 
A PMMA bone cement is a two-component material, comprising a powder (pre-
polymerized PMMA and/or methyl methacrylate (MMA) co-polymer beads, a 
radiopacifier, and an initiator of the polymerization reaction) and a liquid (methyl 
methacrylate (MMA) monomer, an accelerator of the polymerization reaction, and a 
inhibitor of the polymerization reaction) [46] (Table 1).  
 
Table 1 






Poly (poly methyl methacrylate) (PMMA) 
beads   (87.30 wt/wt%) 
  
Methyl methacrylate (MMA)  
(99.1 vol/vol%) 
Benzoyl peroxide (BPO) (2.7 wt/wt%) N, N-dimethyl para-toluidine (DMPT) 
(0.9 vol/vol%) 
 
Barium sulfate (BaSO4) (10.0 wt/wt%)  Hydroquinone (HQ)  
(75 ppm) 
a
Total mass = 40.00 g 
b
Total volume = 14.13 mL 
 
2.5.1.1. Constituents and their functions 
Barium and zirconium are two elements capable of blocking x-rays. In sulfate form 
(BaSO4) or oxide form (ZrO2), each material forms inert powders that are insoluble in 
water, chemically stable, and non-reactive, making them useful as additives for materials 
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that need to appear opaque under x-ray visualization. BaSO4 is a fine, white, inert powder 
that is also used as a contrast medium in x-ray photography of the digestive tract. ZrO2 is 
a white, heavy, amorphous, odorless and tasteless, infusible, water-insoluble powder. It is 
also used as a pigment for paints and in the manufacture of refractory crucibles. BPO is a 
white, crystalline powder that is capable of decomposing into two highly reactive 
peroxide molecules. These reactive molecules are known as free radicals, which initiate 
the polymerization reaction that makes bone cement thicken and finally harden. MMA is 
a colorless liquid, which is also used as a building block for making acrylic plastics. 
DMPT acts like a catalyst and serves to decompose the BPO into the free radical 
molecules that subsequently cause polymerization. HQ is capable of polymerizing by 
itself very slowly over time. It is added to the liquid component to stabilize the monomer 
and to prevent it from undergoing self-polymerization. 
There is a large number of commercially-available plain PMMA bone cement brands, 
with the differences between them being in 1) the relative amounts of the constituents in 
the powder and in the liquid; and 2) the presence or absence of additives, such as a 
coloring agent (chlorophyll) in the powder and/or the liquid and an antibiotic in the 
powder. 
 
With respect to the radiopacifier, clinical practice in VP and BKP is to use either a 
cement brand that has a high radiopacifier content (typically, 30 wt/wt% of the dry 
powder weight) or one that has a low radiopacifier content (typically, 12-15 wt/wt%) but 
to which additional radiopaque substances (for example, more BaSO4 or ZrO2 or            
2-3 wt/wt% of another radiopacifier, such as tantalum powder) have been added. This is 
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necessary to facilitate visualization under fluoroscopy and to monitor cement 
extravasation [47, 48].  
2.5.1.2.  Preparation phases 
There are four preparation or handling phases, namely, mixing, waiting, working, and 
hardening  [49]. The mixing phase starts with the addition of the liquid to the powder (or 
vice versa, depending on the cement brand) and ends when the dough is homogenous and 
stirring becomes effortless. When the liquid and the powder are mixed, the liquid wets 
the surface of the pre-polymerized beads in the powder. Because PMMA is a polymer 
that dissolves in its monomer, the pre-polymerized beads swell and some of them 
dissolve completely during mixing. This dissolution results in a substantial increase in the 
viscosity of the mixture; however, at this stage, the viscosity is relatively low. At the end 
of the mixing phase, the mixture is a homogenous mass and the cement is sticky and has 
a consistency similar to that of toothpaste.  
In the waiting phase, there is further swelling of the beads, thereby allowing 
polymerization to proceed. This leads to an increase in the viscosity of the mixture. 
During this phase, the cement turns into a sticky dough. This dough is subsequently 
tested with gloved fingers every 5 seconds, using a different part of the glove on another 
part of the cement surface on each testing occasion. This process provides an indication 
of the end of the waiting phase when the cement is neither “sticky” nor “hairy.”  
The beginning of the working phase occurs when the cement is no longer sticky, but 
is of sufficiently low viscosity to enable the surgeon to apply the cement. During this 
period, polymerization continues and the viscosity continues to increase; in addition, the 
reaction exotherm associated with polymerization leads to the generation of heat in the 
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cement. In turn, this heat causes thermal expansion of the cement, while there is a 
competing volumetric shrinkage of the cement as the monomer converts to the denser 
polymer. During the working phase, the viscosity of the cement must be closely 
monitored because with a very low viscosity, the cement would not be able to withstand 
bleeding pressure. This would result in blood lamination in the cement, which causes the 
cement to weaken. In total joint replacement, this phase is completed when the cement 
does not join without folds during continuous kneading by hand.   
In the hardening phase, polymerization stops and the cement cures to a hard 
consistency. The temperature of the cement continues to be elevated, but then slowly 
decreases to body temperature. During this phase, the cement continues to undergo both 
volumetric and thermal shrinkage as it cools to body temperature. In total joint 
replacement, the cement is ready for placement in the bone bed when two cement balls 
are touched to each other and they stick together.   
2.5.1.3.    Polymerization processes 
When the cement powder and liquid are mixed (using the powder-to-liquid ratio 
(PLR) recommended by the cement brand manufacturer), two different processes are 
started [50]. First, the powder takes up the liquid, forming a more or less viscous fluid or 
dough. This phenomenon occurs because of the swelling and dissolution processes of the 
powder and the monomer, physical processes that are important for the working 
characteristics of the cement. Second, a chemical process is initiated, which is 
responsible for the final hardening of the bone cement. BPO and DMPT interact to 
produce free radicals in the so-called initiation reaction (Fig. 9). These radicals are able to 
start the polymerization of MMA by adding to the polymerizable double-bond of the 
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monomer molecule. This results in a growing polymer chain that builds up 
macromolecules. Because of the high number of radicals generated, many fast-growing 
polymer chains are formed and, therefore, there is a fast conversion of MMA to PMMA. 
If two growing polymer chains meet, the chains are terminated by combining both, thus 
resulting in an unreactive polymer molecule. The polymerization of MMA is an 
exothermic reaction, resulting in a temperature increase in the curing of the cement.  
 
 
Fig. 9.  A schematic drawing illustrating the initiation of polymerization of a PMMA 





2.5.1.4.   Problematic properties relevant to vertebroplasty and balloon kyphoplasty  
These properties are high exothermic temperature (Tmax), high incidence of 
micropores, high residual monomer content (RMC), and very poor degradability. Tmax as 
high as    100
o 
C have been reported during mixing of some cement brands. 
Consequences of high Tmax include thermal necrosis and evaporation of the monomer, 
which, in turn, may lead to creation of micropores in the curing cement. Micropores may 
also may result from flow and wetting during mixing of the powder and the liquid, 
leading to air entrapment and formation of CO2 formation. Typically, after ~15 minutes 
after polymerization, RMC is ~3-5%, which may decrease to ~1-2% with increase in time 
after  polymerization. High RMC can cause chemical necrosis of periprosthetic tissues. 
Poor degradability means that the cement is not resorbed into the surrounding bone, 
resulting in lack of osseointegration. [49, 50, 51, 52]  
2.5.2.   Calcium phosphate cement  
Calcium phosphate cement (CPC) was first reported,  in 1987, by Brown and Chow 
[53]. Nowadays, however, the term “CPC” refers to a very large family of materials that 
contain Ca and P in various forms (Table 2). There is an array of commercially-available 








Chemical formula and Ca/P ratio for a sample of calcium phosphate compounds [54] 
Compound  Formula Ca/P ratio 
Amorphous calcium phosphate  
(ACP)  
CaxHy(PO4)z . nH2O 1.25-1.55 
Biphasic calcium phosphate (BCP) Ca3(PO4)2 + Ca10(PO4)6(OH)2 1.50-1.67 
Carbonated apatite (dahlite) (CA) Ca5(PO4,CO3)3 1.67 
Calcium deficient hydroxyapatite 
(CDHA) 
Ca10-x(HPO4)x(PO4)6-x(OH)2-x 
0 < x < 1 
1.50-1.67 




Dicalcium phosphate dihydrate 
(brushite) (DCPD) 
CaHPO4•2H2O 1.00 




Octacalcium phosphate (OCP) Ca8(H2PO4)6•5H2O 1.33 
Precipitated hydroxyapatite (pHA) Ca10-x(HPO4)x(PO4)6-x(OH)2-x 
0 < x < 1 
1.50-1.67 
α-tricalcium phosphate (whitlockite)  
(α-TCP) 
α-Ca3(PO4)2 1.50 












Compositions and manufacturers of a sample of commercially-available CPC brands   
[55]   
 
Brand Composition  (Manufacturer) 
α-BSM (Bone Substitute Material) Amorphous CaP + DCPD   (ETEX, Cambridge, 
MA, USA) 
Biopex  75 wt/wt% α-TCP + 18wt/wt% TTCP + 5 wt/wt% 
DCPD + 2 wt/wt% HA  (Mitsubishi Materials Co., 
Saitama, Japan) 
BoneSave 80 wt/wt% tricalcium phosphate (TCP) + 20 wt/wt% 
HA    (Stryker-Howmedica-Osteonics, Mahwah, NJ, 
USA) 




42 wt/wt % β-TCP + 21 wt/wt % MCPM                           
+ 3 wt/wt % β-TCP granules + 5 wt/wt % 
magnesium hydrogen phosphate +  <1 wt/wt % 
sodium hydrogen phosphate and MgSO4  (Synthes, 
Inc., West Chester, PA, USA) 
Calcibon α-TCP + CaHPO4 + CaCO3 + pHA 
(Biomet Europe, Dordrecht, The Netherlands) 
Eurobone TCP     (F-H Orthopedics, Heimsbrum, France) 






A CPC consists of two parts: a powder mix, which contains dry calcium phosphate 
particles, and an aqueous or wetting solution, which, in many cases, is de-ionized 
distilled water. The CPC is formed by the cementing action of acidic and basic calcium 
phosphate compounds on wetting the powder with the aqueous solution. Dissolution of 
the particles (quickly or slowly, depending on the composition and pH of the aqueous 
solution) and mass transport are the primary functions of the aqueous solution, in which 
the dissolved reactants form a supersaturated (very far away from the equilibrium) 
microenvironment with regard to precipitation of the final products. The relative stability 
and solubility of various calcium phosphates is the major driving force for the setting 
reactions that occur in these cements. Mixing of the powder and the aqueous solution, in 
a suitable proportion, gives a self-setting mass. That is, the mixing induces various 
chemical transformations, where crystals of the initial calcium phosphate(s) rapidly 
dissolve(s) and precipitate(s) into crystals of CDHA or DCPD, with possible formation of 
intermediate precursor phases (for example, ACP and OCP). During precipitation, the 
newly formed crystals grow and form a web of intermingling microneedles or 
microplatelets of the final products, thus providing mechanical rigidity to the hardened 
cements. In other words, entanglement of the newly formed crystals is the major 
manifestation of setting. For the majority of apatite cements, water is not a reactant in the 
setting reaction; therefore, only a small quantity of water is needed for setting of the 
cement.   
The hardening reaction of the cement, which forms nanocrystalline HA as the 
product, is isothermic and occurs at physiologic pH so tissue damage does not occur 
during the setting reaction [56]. Because CPC is brittle, it is used for non-load-bearing 
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applications, such as dental and cranio-facial applications. CPC has two significant 
advantages over pre-formed, sintered ceramics. First, the CPC paste can be sculpted 
during surgery to fit the contours of the application (for example, a wound or in VP or 
BKP). Second, the nanocrystalline HA structure of the CPC makes it osteoconductive, 
causing it to be gradually resorbed and replaced with new bone. Recent work with CPC 
has focused on improving its mechanical properties, making premixed cements, making 
the cement macroporous, and seeding it with cells and growth factors [56]. 
2.5.2.1.  Setting reactions 
Setting of a CPC is a continuous process that always starts with dissolution of the 
initial compounds in an aqueous system [54]. This process supplies calcium and 
phosphate ions into the solution, where they interact chemically and precipitate in the 
form of either the end-products or precursor phases, which causes the cement setting. 
Some researchers showed that when TTCP and DCPA powders are mixed in double-
distilled water, both powders dissolve. The dissolved calcium and phosphate ions in the 
solution then precipitate in the form of CDHA on the surface of the powders. The 
precipitate can be either a gel or a conglomerate of crystals. Therefore, the hardening 
mechanism is either a sol-gel transition of ACP or entanglement of the precipitated 
crystals of other calcium phosphates [54].  
The chemical reactions that take place during the setting of a CPC depend on its 
chemical composition; however, only two major chemical types of setting reactions are 
possible [54]. The first type occurs according to the classical rules of an acid-base 
interaction; that is, an acidic calcium phosphate reacts with a basic one to produce a 
neutral compound. The following CPC cement is a typical example because TTCP 
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(basic) reacts with DCPA (slightly acidic) in an aqueous suspension to form a 
precipitated poorly crystalline HA (slightly basic): 
 
               Ca4(PO4)2O + CaHPO4 → Ca5(PO4)3OH      (1) 
 
Formation of HA according to Eq. (1) releases neither acidic nor basic byproducts. 
Thus, the liquid phase of the cement remains at a near constant pH of 7.5 for the TTCP 
+DCPD formulation and 8.0 for the TTCP + DCPA formulation. Another example of the 
acid-base interaction involves β-TCP (almost neutral) reacting with MCPM (acidic) to 
form DCPD (slightly acidic): 
 
β-Ca3(PO4)2 + Ca(H2PO4)2·H2O + 7H2O → 4CaHPO4·2H2O      (2) 
 
The second type of setting reaction might be defined as hydrolysis of a metastable 
calcium phosphate in aqueous media. As the result, both the initial and final compounds 
have the same Ca/P ionic ratio. The solid part of such a formulation might be considered 
a single-phase cement powder. Cements made of ACP + an aqueous solution, α-TCP + an 
aqueous solution, β-TCP + an aqueous solution, nanocrystalline TTCP + an aqueous 
solution, or γ-radiated TTCP + an aqueous solution are typical examples, with each of 
them re-crystallizing to CDHA upon contact with water: 
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          3Ca3(PO4)2·nH2O → Ca9(PO4)5(HPO4)OH + (3n-1)H2O               (3) 
 
         3α-Ca3(PO4)2 + H2O → Ca9(PO4)5(HPO4)OH                (4) 
 
2.5.2.2.   Problematic properties relevant to vertebroplasty and balloon kyphoplasty  
These properties are inappropriate setting/hardening times, poor rheological 
parameters, lack of macroporosity, and inadequate mechanical properties. CPCs should 
set slowly enough to provide sufficient time to finalize the surgical procedure but fast 
enough to prevent delaying it. Ideally, good mechanical properties should be reached 
within minutes after initial setting. Two main experimental approaches are used to study 
the cement setting process: a batch approach and a continuous approach. In the batch 
approach, the setting reaction is stopped at various times and the resulting samples are 
analyzed. There are currently two standardized methods that use this approach; namely, 
the Gillmore needle method (ASTM C266-89) [57] and the Vicat needle method   
(ASTM C191-92) [58]. Each method involves visually examining the surface of a cement 
sample to decide whether it has set, with setting denoted when no mark can be seen on 
the surface after indentation by the needle. A light and thick needle is used to measure 
initial setting time (I) while a heavy and thin needle is to determine final setting time (F). 
In a clinical procedure, the cement paste should be implanted before I and terminated 
after F. The cement should not be deformed between times I and F because at that stage 
of the setting process any deformation could induce cracks in the cement. The setting 
process may be monitored in real time by non-destructive methods (the continuous 
 30 
approach), such as pulse echo ultrasound, isothermal differential scanning calorimetry, 
and alternating current impedance spectroscopy [59]. It should be noted that the setting 
time for a CPC often corresponds to an earlier stage in the overall setting reaction, 
typically 5 – 15 % of the overall reaction, while the end of the cement setting is typically 
reached after several days. 
The two most important rheological properties of calcium phosphate pastes are 
viscosity and injectability. The viscosity of the cement dough when it is delivered from 
the syringe to the fractured VB must not be too high (otherwise manual injection would 
be very difficult) or too low (which would increase the likelihood of extravasation of the 
cement). Viscosity in the range of 100 – 2,000 Pa·s is considered to be adequate [60]. 
Mechanical mixing, for example, using an electric mixing machine, allows a cement 
paste to be obtained within 80 s and enables a rapid and reliable filling of the application 
syringe [61]. Besides, a cement powder and an aqueous solution might be placed into a 
syringe and mixed inside a shaker to produce a consistent cement paste of the desired 
viscosity [62]. Mechanical mixing has been found to decrease both the mean viscosity of 
the curing cement paste and variability in the viscosity at a given time [63].  
Potential problems that may arise during injection of a CPC cement paste into the 
fractured VB bone include particles might be flushed away into the blood stream, syringe 
plugging, cannula plugging, phase separation, and paste extravasation [64]. The primary 
cause of syringe plugging is high permeability of the solid bed for the liquid, where the 
liquid continuously flows faster than the particles. The cause of cannula plugging is too 
large particles, typically more than one-third of the cannula diameter. Phase separation 
(sometimes called filter pressing) is a phenomenon in which there is de-mixing into a thin 
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paste, which is extruded, and a thick mass, which remains inside the syringe. That is, the 
liquid comes out of the syringe but a good amount of the powder particles remain in it. 
Phase separation is avoided when the cement paste has good cohesion, which can be 
accomplished by, for example, adding cohesion promoters (such as 1 % aqueous solution 
of sodium alginate) to the cement aqueous solution [65]. One of the causes of cement 
paste extravasation into neighboring tissues is its low viscosity.  
The ease of injection of the cement paste is defined as its injectability. Specifically, in 
the context of VP and BKP, cement injectability is the ability of the cement paste to be 
extruded through a small hole of a long needle (typical dimensions of 1 mm diameter and 
10 cm length) either directly into the fractured vertebral body (in the case of VP) or into 
the cavity created in the fractured vertebral body by the bone tamp (in the case of BKP). 
There are a number of options available for improving cement injectability, examples 
being use of a shorter cannula with a larger diameter and a cement in which the powder 
has large particles [66].  
In theory, CPCs can be prepared with almost any porosity. However, for most 
commercially-available CPC brands, pore size is, typically, 8 – 12 μm in diameter and, 
after the cement is set, about 40 – 50 % of its volume is occupied by pores [67]. The pore 
dimensions of hardened cements are too small to allow fast bone ingrowth. In other 
words, the cement lacks sufficient macroporosity. After injection, bone cells are able to 
degrade the hardened cements layer-by-layer only, starting at the bone-cement interface 
throughout its inner part [68].  
Having a ceramic origin, the set products of all CPCs are brittle and, as such, the 
cements have low compressive strength (typically, 10-100 MPa), very low impact 
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resistance, and a very low tensile strength (typically, 1-10 MPa). There are a number of 
ways of improving the mechanical properties of CPCs, a popular one being addition of 
water-soluble polymers to the liquid; for example, ultimate compressive strengths of 
composites of α-BSM with bovine serum albumin and polycations (polyethylenimine and 
polyallylamine hydrochloride) were up to two and six and times, respectively, greater 
than that of α-BSM  [69].  
2.6.   Design of experiments 
In an experiment, one or more process variables (or factors) can be deliberately 
changed in order to observe the effect the changes have on one or more response 
variables. The design-of-experiments (DOE) method is an efficient procedure for 
planning experiments so that the data obtained can be analyzed to yield valid and 
objective conclusions [70,71].  
DOE begins with determining the objectives of an experiment and selecting the 
process factors for the study. An experimental design is the laying out of a detailed 
experimental plan in advance of doing the experiment. Well-chosen experimental designs 
maximize the amount of information that can be obtained (results collected), for a given 
amount of experimental effort.  
The statistical theory underlying DOE generally begins with the concept of process 
models. It is common to begin with a process model of the “black box” type, with several 
discrete or continuous input factors that can be controlled (that is, varied at will by the 
experimenter) and one or more measured output responses. The output responses are 
assumed to be continuous. Experimental data are used to derive an empirical 
(approximation) model linking the outputs and the inputs. These empirical models 
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generally contain first- and second-order terms. Often, the experimenter has to account 
for a number of uncontrolled factors that may be discrete, such as different machines or 





              Fig. 10.  A schematic drawing of a “black box” process model [71].  
 
The most common fit of an empirical model to experimental data takes either 




                          Y = β0+ β1X1 + β2X2 + β12X1X2 + experimental error,               (5) 
 
where Y is the response for given levels of the main effects,  X1 and X2, and 
the X1X2 term is included to account for a possible interaction effect between X1 and X2. 
The constant, β0, is the response of Y when both main effects are 0. 
  A linear model with three factors X1, X2, X3 and one response, Y, can be written as 
 
   Y = β0 + β1X1 + β2X2 + β3X3 + β12X1X2 + β13X1X3 + β23X2X3 + β123X1X2X3  
  + experimental error                                                                                        (6) 
 
The three terms with single Xs are the main effects terms. There are 3 two-way 
interaction terms and 1 three-way interaction term. When the experimental data are 
analyzed, all unknown β parameters are estimated and the coefficients of the X terms are 
tested to see which ones are significantly different from 0. 
A second-order (quadratic) model (typically used in response surface DOE with 
suspected curvature) does not include the three-way interaction term but adds three more 
terms to the linear model. Thus, the expression becomes 
 
Y = β0 + β1X1 + β2X2 + β3X3 + β12X1X2 + β13X1X3 + β23X2X3 +  
     + β11 X1
2 + β22 X2
2 + β33 X3
2 + experimental error                                                   (7) 
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Clearly, a full model could include many cross-product (or interaction) terms 
involving squared Xs. However, in general, these terms are not needed and most DOE 
software defaults to leaving them out of the model. 
2.6.1.   Response surface methodology 
Response surface methodology (RSM) is a DOE tool that allows a detailed statistical 
analysis of a problem in which a response of interest is influenced by several         
variables [71,72]. With this tool, the values of variables that lead to an optimized value of 
the response may be obtained. In most RSM problems, the true response function, f, is 
unknown. In order to develop a proper approximation for f, the experimenter usually 
starts with a low-order polynomial in some small region. If the response can be defined 
by a linear function of independent variables, then the approximating function is a     
first-order model. However, if there is a curvature in the response surface, then a    
higher-degree polynomial should be used; for example, the approximating function with 
two variables is called a second-order model.  
In general, all RSM problems use either a first- or a second-order model or a mixture 
of the two. In each model, the levels of each factor are independent of the levels of the 
other factors. In order to get the most efficient result in the approximation of 
polynomials, proper experimental design must be used to collect data. Once the data are 
collected, the method of least squares is used to estimate the parameters in the 
polynomials. The response surface analysis is performed by using the fitted surface. 
Response surface designs are types of designs for fitting a response surface.  
To summarize, then, RSM involves 1) understanding the topography of the response 
surface (local maximum, local minimum, and ridge lines), and 2) finding the region 
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where the optimum response occurs. The goal is to move rapidly and efficiently along a 
path to get to a maximum or a minimum response so that the response is optimized. 
2.6.2.  Advantages and shortcomings of response surface methodology 
RSM has several advantages, four of which are highlighted here. First, it helps to 
establish a relationship (called the approximate function) between the response variable 
(Y) and the input/control variables X1, X2, X3,….,Xk that can be used to predict response 
values for given settings of the control variables. Second, it helps to determine, through 
hypothesis testing, the significance of the factors whose levels are represented by X1, X2, 
X3,….,Xk Third, it helps to determine the optimum settings of the control variables that 
result in a maximum (or a minimum) response over a certain region of interest. Fourth, it 
provides a way of rigorously choosing a few points in a design space to efficiently 
represent all possible points and, as such, reduces the number of experimental runs 
required for studying the significance of different factors that may affect the response of 
interest. 
Four shortcomings of RSM are now described.  First, large variation in the factors can 
be misleading (error, bias, no replication). Second, estimating the accuracy of an 
approximation is challenging; in other words, determining the magnitude of the 
approximation errors is difficult. Third, RSM is a local analysis; the developed response 
surface is invalid for regions other than the studied ranges of factors. Fourth, RSM is 
sensitive to system noise. In RSM, it is assumed that the experimental noise factors are 
controllable during process development for purposes of a designed experiment. This 
assumption reduces the robustness of RSM models. In this respect, Taguchi has modified 
RSM and developed a new approach known as robust parameter design (RPD) 
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methodology that makes RSM models insensitive (or robust) to changes in a set of 
uncontrollable factors [70,72].  
2.6.3. Process optimization  
The optimal region to which to run a process is usually determined after a sequence 
of experiments has been conducted and a series of empirical models obtained. In many 
engineering and science applications, experiments are conducted and empirical models 
are developed with the objective of improving the response of interest. From a 
mathematical point of view, the objective is to find the operating conditions (or factor 
levels) X1, X2, ..., Xk that maximize or minimize the  system response variables Y1, Y2, 
....Yr. In experimental optimization, different optimization techniques are applied to 
the fitted response equations. Provided that the fitted equations approximate adequately 
the true (unknown) system responses, the optimum operating conditions of the model will 
be close to the optimum operating conditions of the true system. 
The experimental optimization of response surface models differs from classical 
optimization techniques in at least three ways. First, experimental optimization is an 
iterative process; that is, experiments conducted in one set of experiments result in fitted 
models that indicate where to search for improved operating conditions in the next set of 
experiments. Thus, the coefficients in the fitted equations (or the form of the fitted 
equations) may change during the optimization process. In classical optimization, the 
functions to optimize are supposed to be fixed and given. Second, the response models 
are fitted from experimental data that usually contain random variability due to 
uncontrollable or unknown causes. This implies that an experiment, if repeated, will 
result in a different fitted response surface model that might lead to different optimum 
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operating conditions. Therefore, sampling variability should be considered in 
experimental optimization. In classical optimization, the functions are deterministic and 
given. Third, in response models, the fitted responses are local approximations, implying 
that the optimization process requires the input of the experimenter (a person familiar 










































3.1.  Injectable bone cements for use in vertebroplasty and balloon kyphoplasty 
There is a large body of literature on the direct effect of one or more intrinsic or 
extrinsic variables on a wide collection of properties of both PMMA bone cements and 
CPCs for use in VP and BKP. Intrinsic variables refer to compositional parameters, such 
as presence or absence of reinforcing fillers in the cement powder, whereas extrinsic 
variables refer to preparation/fabrication parameters, such as PLR. Key features of a 
sample of these literature reports are given in Tables 4 and 5.  The observations from this 
review are 1) of the properties of PMMA bone cement that were characterized as 
“problematic” (see sub-section 2.5.1.4), only Tmax and RMC have been investigated 
[75,76,81-83]); and 2) there have been many studies involving properties of CPC that 






















Table 4  
Summary of studies on direct effect of one or more variables on properties of PMMA 
bone cement for VP and BKP 
Cement 
property/properties 






Addition of 2% 
aqueous solution of 
sodium hyaluronate 
(0-50%) to cement 
liquid 
Decrease in each 
property  













cement powder    (15 
wt/wt% of ZrO2, 
BaSO4, Lipiodol) or to 
cement liquid  (7.5 










   
 
Ec; YS; maximum 
exotherm 
temperature (Tmax);  
 
Addition of castor oil 
(2.5-12.0 wt/wt%) to 
cement liquid 
 
Decrease in each 
property 
 




   
 
 
   
YS; Ec; Tmax;  initial 
viscosity; setting 
time (tset) 
Addition of bone 
marrow (0-7 mL) to 
cement liquid 













under which test was 
conducted  (Tamb) 
Mean time to reach 
a selected viscosity 
decreased with 
increase in Tamb 
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Table 4  
Summary of studies on direct effect of one or more variables on properties of PMMA 
bone cement for VP and BKP 
Cement 
property/properties 






PLR  Increase in PLR 
led to a significant 
increase in 
polymerization 
rate; influence of 
PLR on fatigue 
limit not significant  
Lewis et al. [78]
 












Addition of an 
antibiotic (5 wt/wt% 
ciprofloxacin alone or 
in combination with 
another antibiotic (3 
wt/wt% vancomycin)) 









strength decreased  
 















At any mixing 
time, viscosity 
significantly lower 
when cement was 
oscillatory mixed 
 
Baroud et al. [63] 
 
 
    
    
Setting temperature 







influence on any of 
the properties 
Baroud et al. [80]  
  
 
    








Surface treatment of 
MTiO3 particles (M: 
Ba or Sr) added to the 
cement powder as 
radiopacifier (none vs 
silanated) 
 
Silanation led to 
increases in each 
property, with the 




Carrodeguas et al. 
[81] 
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Table 4  
Summary of studies on direct effect of one or more variables on properties of PMMA 
bone cement for VP and BKP 
Cement 
property/properties 
Variable(s) Influence Reference 
UCS; viscosity; 
Tmax; tset 
Size of ZrO2 spheres 
added as radiopacifier 
(microsphers vs 
nanospheres) 
UCS and viscosity 
lower when 
microspheres were 
used; Tmax and tset 
are both unaffected 
With each type of 
sphere, viscosity 
increased with 
increase in sphere 
content  




      In addition to the studies reviewed above (Table 4), Carrodeguas et al. [81] 
determined the tdough, tset, Tmax, RMC, UCS, Ec, and injectability of 8 cements. The 
compositions of these cement differed in terms of the following variables: amount of 
PMMA, MTiO3  (M = Ba or Sr), and BPO in the powder; amount of MMA and              
4-N,N-dimethylamino benzyl alcohol in the liquid; and PLR. Thus, it is difficult to isolate 








Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
Viscosity Mixing method   
(manual versus 
oscillatory mixing) 
For one cement 
(ChronOS Inject),  
viscosity significantly 
lower when cement was 
oscillatory mixed; for 
another cement 
(Bioplex), change was 
not significant 




   
Injectability Resting time; that 
is, time over which 
cement set without 
further mixing 
Injectability decreased 
with increase in resting 
time 




   
Injectability Agitation at a 
given resting time 
(none versus 
mixing at 1600 
rpm for 30 s)  
Agitation led to 





   
 
UBS (3-point 
flexure); Eb (3-point 
flexure); WOF (3-
point flexure)  
 
Amount of 
chitosan lactate in 
the liquid 
 
For a given PLR, each 
property increased with 
increase in chitosan 
content 
 
Weir et al. [84] 
 
 
    
 PLR For a given chitosan 
content, each property 











   
 44 
Table 5 
Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 








SPS, PEO) or 
bovine serum 
albumin (BSA) to 
the cement paste 
during setting    
Influence depended on 
the additive; e. g., PAH 
and PEI composites 
showed very large 
increase; PDMAC and 
SPS composites 
showed slight drop; 
PEO composites 
showed little or no 
increase; and BSA 
composites show large 
increase. 
In general, ETF results 
followed the same 
trends as the UCS 
results  





   
Injectability; 
doughing time (td); 
initial setting time (I); 
final setting time (F) 
PLR Increase in each 
property with decrease 
in PLR 
Khairoun et al. [66] 





At a given PLR, 
decrease in each 
property with increase 
in [SPC] 
 
    
    
I; F; UCS PLR 
 
At a given [SPC], I 
increased, F increased, 
and UCS decreased 
with decrease in PLR 
 









At a given PLR, each 
property decreased  
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Table 5 
Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
Injectability; UCS 
  






dioxide (TiO2), or 
calcium carbonate] 
to cement powder 
 
PLR 
At a given PLR, filler 
increased injectability 
 
At a given filler 
content, injectability 
decreased markedly 
with increase in PLR 
 
At a given PLR, 
addition of DCPA or 
TiO2 filler did not 
significantly influence 
UCS 




   
Setting time (T); 
diametral tensile 
strength (DTS)   
Addition of an 
antibiotic 
(flomoxef sodium) 
to cement powder  
T increased and DTS 
decreased with addition 
of antibiotic 
Takechi et al. [88] 
 
 
 Very slight increase in 
T but sharp decrease in 





   
    
F; DTS Sterilization of 
cement powder 
(steam; dry heat; 
EtO gas; -
irradiation) 
Sterilization led to 
higher F and lower 
DTS  
Tekechi et al. [89] 
  With -irradiation, F 
increased and DTS 




    
Injectability; UBS (3-






UBS increased, and Eb 
increased  with increase 
in PLR  




Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
Injectability  PLR Property increased with  
decrease in PLR 
Bohner et al. [91] 
 Liquid 
composition (water 
vs 1% polyacrylic 
acid sodium salt 
(PAA) vs 0.2% 
xanthan) 
At a given PLR, 
injectability was in 












    
Injectability; UCS  PLR 
 
At a given PLR, 
injectability with water 
lower than with citrate. 
Same trends for UCS 








sodium citrate vs 
water)   
 
With each liquid, UCS 


















Each time decreased 
with increase in PLR 
 
Barralet et al. [93] 
 
UCS Addition of 
sodium citrate 
solution or citric 
acid solution to 
cement liquid 
At a given PLR, UCS 
decreased with increase 
in sodium citrate 
concentration but 
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Table 5 
Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
UCS Pre-compaction 
pressure of cement 
paste (PLR = 3.3 
and 500 nM of 
additive solution) 
Influence complex  







UCS -TCP content of 
cement powder  
Property increased 
linearly with increase in 
-TCP content  










Injectability; I; F; 
UCS;  UBS   (4-point 
bend)  
Addition of (poly 
(4-HMA) to 
cement  liquid 
Influence depended on 
the 4-HMA content; e. 
g., with 5 wt/wt%, 
injectability increased 
but after a longer period 
it decreased; I 
decreased;   F 
decreased; UCS 
increased; and UBS 
increased relative to 
values when there was   
no 4-HMA   





   
Injectability  Addition of an 
adjuvant, such as 
sodium 
glycerophosphate, 
lactic acid, or 
glycerol to cement 
liquid 
With each additive, 
property increased  
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Table 5 
Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 










(SA) to cement 
powder 
With each additive, 
injectability increased 
and viscosity decreased 
Influence of additive 
content on injectability 
depended on additive;    
e. g., with CMC, 
injectability increased 
with increased content 
but that was not the 
case with AGAR.  








    
I; injectability; UCS A porogen (acetic 
acid versus citric 
acid) dissolved in 
the cement liquid 
Porogen led to 
significant decreases of 
I and UCS 
Herasaki et al. [97] 
 
  Cement prepared with 
citric acid showed 
better injectability 
compared to CPC 









UCS Addition of gelatin 
to cement powder 
Property increased up 
to gelatin content of            
8 wt/wt% after which it 
decreased 




Addition of   
wt/wt% of either 
CaTiO3 or HA 
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Table 5 
Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
T; injectability; UBS 
(4-point flexure); 
WOF (4-point 





vs aqueous sodium 
phosphate-HPMC) 
With sodium 
phosphate, both T and 
injectability decreased 
with increase in content 
Burguera et al. [99] 
    
   
With sodium 
phosphate-HPMC, 
marginal influence of 
content on T, UBS, 
WOF, and Eb while 
injectability increased 
with content up to        
0.5 mass% after which 












Pressure applied to 




With water, increase in 
property with increase 
in pcomp; with 
phosphate, decrease in 
property with increase 
in pcomp 
 










For a given pcomp, UCS 
higher when water was 
used compared to when 
















Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
UCS; fracture 
toughness (JIC); DTS 
 
Addition of fibers 
(carbon, 
polypropylene, 
nylon 66) to 
cement powder 
For a given fiber, 
volume fraction 
(Vf)  
UCS decreased with 
addition of each of the 
fibers. Influence on JIc 
depended on the fiber; 
thus, with  both C and 
nylon, it increased with 
increase in Vf but with 
propylene, it was 
practically constant 
with increase in fiber 
content until 5% after 
which it decreased  
 
 
Influence on DTS 
depended on the fiber; 
thus, with C, it 
increased up to fiber 
content of 3 wt/wt% 
after which it decreased 
; with each of the other 
two fibers, influence 
was marginal  
dos Santos et al. 
[101] 





















Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
UCS; compressive 
fracture energy; Ec 
 
Composition of 





With polypeptide graft 
solution, Ec decreased 
with polypeptide 
content regardless of 
liquid composition 
 
With polypeptide graft 
solution, influence on 
each of the other  two 
properties depended on 
the property, the liquid 





influence on each of the 
properties depended on 
the property, the liquid 
composition, and the 
polypeptide content  











DTS Addition of 
NaHCO3 to cement 
powder 


















Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
UCS; T Ca/P ratio of 
cement powder 
UCS decreased with 
decrease in Ca/P ratio;  
Burguera et al. [104] 
 Composition of 
liquid (NaHPO4 vs 
water) 
 
With each liquid, T was 
not significantly 
affected by Ca/P ratio 
 
At a given Ca/P ratio, 
when NaHPO4 was 
used, UCS was, on 
average, lower than 
when water was used; T 
was significantly higher 




   
    
I; injectability; UCS 
 
Fluidicant (citric 
acid (CA) versus 
no fluidicant) 
I unaffected but 
injectability increased 
when CA was used 
When CA used, I 
increased with increase 
in CA content, up to      
~1.8 wt/wt%, after 
which it decreased. 
Same pattern seen for 
injectability results 
1.5 wt/wt% CA 
retarded evolution of 
UCS 
Sarda et al. [105]
 
    
    
UCS; Weibull 
compressive modulus  
Compaction 
pressure (pcomp)  
Each property increased 
with increase in pcomp  





   
Injectability; I 
 
Addition of gelatin 
microspheres to 
cement 
Each property increased 
slightly (25-45%) 
Habraken et al. [107] 
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Table 5 
Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
DTS; UCS 
 





(distilled water vs 
phosphate 
solution) 
Influence of each 
variable was small but 
significant 
With water, DTS 
unaffected but UCS 
decreased with decrease 
in PLR. With 
phosphate, each 
property was unaffected 













implants in the 
diaphysis of femoral 
bones of New 




powder in cement 
powder 
 
Marked decrease in 
property with increase 
in Zn content 
 
 

















Each time increased 
with addition of a 
radiopacifier 
 




















Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
UBS (3-point 
flexure); WOF   (3-
point flexure); Eb (3-
point flexure); UCS; 






With addition, UBS, 
WOF, Eb, UCS 




With increase in -TCP 
aggregates content, 
UCS increased up to 
content of 20 wt/wt% 
and then decreased; but 
I, F, and injectability 
each dropped 
continuously 





   







UCS when ratio = 4:1 >  
UCS when ratio = 2:3 > 
UCS when ratio = 2:5 
 





   
I; UCS Addition of a 
liposoluble statin, 
simvastatin (SIM), 
to the cement 
powder 
 
Addition of an air-
entraining agent, 
sodium doceyl 
sulfate (SDS), to 
the cement liquid 
No significant effect on 





With no SDS, SIM had 
no significant influence 
on UCS; with 300 mM 
SDS, UCS decreased 
with increase in SIM  
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Table 5 
Summary of a sample of studies on direct effect of one or more variables on properties of 
calcium phosphate cements 
Cement property/ 
properties 
Variable(s) Influence(s) Reference 
I; F; UCS Amount of 
colloidal silica 
suspension added 
to cement liquid 
I decreased, F 
decreased, and UCS 
increased significantly 
Heraskai et al. [114] 
  For cements that 
contained the colloid, I 
decreased, F decreased, 
and UCS increased 
continuously with 





   
UBS; Eb; WOF  Amount of  bovine 




At a given value of BC, 
both UBS and Eb 
increase but little effect 
on WOF, with increase 
in PLR 
 
At a given PLR, small 
decrease in UBS, small 
increase in Eb, and 
large increase in WOF, 
with increase in BC  
Moreau et al. [115] 
 
 
MC3T3E1: clonal murine calvarial cells; PAH: poly(allylamine hydrochloride);  
PEI: poly(ethylenimine); PDMAC: poly(diayldimethylammonium chloride);  
SPS: poly(sodium 4-styrenesulfonate); PEO: poly(ethylene oxide);  




In addition to the above-reviewed studies (Table 5), Lopez-Heredia et al. [116] 
determined I, F, injectability, UCS, specific compressive strength (= UCS/density), 
indirect strength (ITS) (using the Brazilian test method), and specific indirect tensile 
strength (= ITS/density) of 7 cements. However, differences in the compositions of the 
cements (amounts of fibrin, fibrinogen, and thrombin) and the amount of liquid used in 
preparing the cement pastes make it difficult to isolate the influence of a variable (fibrin 
amount and thrombin type (long-setting variant versus fast-setting variant) on a cement 
property. 
3.2.    Response surface methodology  
There are a multitude of reports in the literature on the application of RSM to a very 
large array of fields of study, ranging from materials science to fuel processing 
technology and from manufacturing engineering to renewable energy. Some aspects of a 
small sample of these reports are now presented. 
Thirumalaikumarasamy el al. [117] reported on the influence of atmospheric plasma 
spraying parameters (input energy (IE), stand-off distance (SOD), and powder feed rate 
(PFR)) on the porosity level of an alumina coating on AZ31B magnesium alloy. The 
optimum (minimum achievable) porosity level was determined to be 4.44 vol/vol%, with 




In the case of friction-stir-welded AA6061–T6 aluminum alloy joints,         
Rajakumar et al. [118] developed empirical relationships that relate six friction stir 
welding input parameters (rotational speed (RS), welding speed (WS), axial force (AF), 
shoulder diameter (SD), pin diameter (PD), and tool hardness (TH)) to three properties of 
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the joints  (tensile strength, hardness, and corrosion rate). The combination of the values 
of these process parameters that would simultaneously maximize tensile strength, 
maximize hardness, and minimize corrosion rate were computed to be                           
RS = 1,100 rev min
-1
, WS = 80 mm min
-1
, AF = 8 kN, SD = 15 mm, PD = 5 mm, and  
TH = 45 HRc.  
  Bhushan [119] investigated the effects of cutting speed (CS), feed rate (FR), depth of 
cut (DC) and nose radius (NR) on power consumption and tool life in computerized 
numerically-controlled turning of a composite (7075 Al alloy reinforced with 15 wt/wt% 
SiC particle size: 20-40 µm) using a 6615-grade tungsten carbide cutting tool. The 
minimum power consumption (1,116 watt-hours) and maximum tool life (6.6 min) were 
found to occur with CS = 90 m min
-1
, FR= 0.15 mm rev
-1
, DC = 0.20 mm, and             
NR = 0.42 mm.  
Gil et al. [120] used RSM for optimizing carbon adsorbents for the highest possible 
CO2 capture capacity of activated carbons. Carbon precursors were prepared by 
incorporating potassium chloride (KCl) into the Re and No1 cured resins, which were 
impregnated with KCl at ambient temperature (ReKCla and No1KCla precursors) or 
boiled with a saturated KCL solution (ReKClb and No1KClb precursors).                     
The No1KCla-600 carbonized was prepared from No1KCla precursor carbonized at   
600
o
 C and the No1KClb-1000 carbonized material was prepared from No1KClb 
precursor carbonized at 1000
o
 C. The blend of olive stone to resin mixed with             
hexa methylene teramine (28.6 wt/wt%) and heated at 170
o
 C for 30 min resulted in the 
No2OS precursor. The No2OS precursor was carbonized at 1000
o
 C to obtain the 
No2OS-1000 carbonized material. The activation parameters (temperature and burn-off 
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degree) did not influence the capture capacity of the evaluated carbonized materials in a 
uniform way. Thus, 1) for No1KCla-600, the maximum CO2 capture capacity was        
9.3 wt/wt% and it was reached at an activation temperature of 809
o 
C and a burn-off 
degree of 22%; and 2) for No1KClb-1000 and No2OS-1000, the maximum CO2 capture 
capacity and activation temperature were 7.5 wt/wt% and 800
o
 C and 7.3 wt/wt% and 
942
o
C, respectively, regardless of the burn-off degree.   
In an RSM optimization study involving air cyclones used as separators, which rely 
on centrifugal forces to separate particles from a gas stream, Elsayed et al. [121] found 
that the combination of cyclone geometrical parameters that led to the minimum pressure 
drop were as follows: vortex finder diameter = 0.487 m, inlet height = 0.628 m,                  
inlet width = 0.203 m, vortex finder length = 0.733 m, total cyclone height = 4.852 m, 
cylinder height = 1.633 m,  and cone tip diameter = 0.383 m.   
  Cisneros-Pineda et al. [122] used RSM to investigate the effect of the amount of 
BaSO4 and the amount of a co-monomer, diethyl amino ethyl methacrylate on the 
properties of a PMMA bone cement. The interaction between these two variables 
produced significant effect on a number of cement properties, such as Tmax, setting time, 
RMC, and injectability.  
Direct and interaction effects of three variables on a number of properties of a PMMA 
bone cement were studied by Lopez et al. [11]. The variables were the amount of BPO, 
the amount of a crosslinking agent (ethylene glycol dimethacrylate (EGDMA)), and PLR. 
The cement properties were UCS, Ec, tdough, tsetting, Tmax, tons, and the critical curing rate 
(CCR). tons is time at the onset of cure and it is defined as the time when the complex 
viscosity increased sharply. CCR is defined as the slope of the complex viscosity-versus-
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mixing time curve at tons. There were significant direct effects of the amount of EGDMA 
on compressive strength, the amount of EGDMA on tset, the amount of BPO on tset, the 
amount of EGDMA on Tmax, and PLR on Tmax.  Furthermore, there were significant 
interactive effects between the amount of EGDMA and the amount of BPO on both tdough 
and CCR.    
O’Hara et al. [123] used DOE to determine the factors that have the greatest effect on 
the mechanical and handling properties of an apatitic calcium phosphate cement. The 
optimum predicted values were compressive strength = 26 MPa, injectability = 30%, I = 
6 min, and F = 13 min. These property values were obtained with a cement powder that 
contained no HA, a cement liquid of 5 wt% Na2HPO4, and a PLR of        2.86 g mL
-1
. It 
was found that the material properties were interrelated; for example, increasing 
compressive strength had a negative effect on the handling properties and vice versa. The 
authors did not include a statistical analysis of the interaction effects.  
Direct and interaction effects of compositional variables on the ultimate compressive 
strength of CPC composites comprising calcium phosphate, multi-walled carbon 
nanotubes (MWCNTs), and bovine serum albumin (BSA) were studied by                  
Low et al. [124]. The optimum compressive strength of the composite was found to be 
12.5 MPa, which was achieved when the composition of the composite was 84.5 wt/wt% 








4.1.    Case Study #1: Maximum exotherm temperature of a PMMA bone cement  
4.1.1.   Experimental details 
A radiolucent cement powder was used, while the liquid was that in a commercially-




; Medtronic Spinal & Biologics, 
Memphis, TN, USA) but modified by addition of a quaternary amine co-monomer 
(QACM). The cement powder and liquid were mixed in a polyethylene bowl that was 
open to the laboratory atmosphere. 
The maximum exotherm temperature (Tmax) of the cement was determined by using 
the protocols given in ISO 5833 standard [125]. After mixing the cement powder and 
liquid, the dough was poured into a circular ultra-high-molecular-weight polyethylene 
(UHMWPE) mold (diameter and height = 60 mm and 20 mm, respectively), equipped 
with a thermocouple, positioned with its junction 3.0 ± 0.5 mm above the base of the 
mold. An UHMWPE cover (8 mm thick) was placed over the dough in the mold to 
squeeze out excess dough. The mold was placed in a thermostatically-controlled water 
bath, with the temperature maintained at 37
o 
C. A record of the temperature of the cement 
as a function of polymerization time, up to the point when the cement was fully 
polymerized, taken continuously, was exported to a data acquisition system. Tmax was 
computed from this temperature-versus-time record, per ISO 5833. The results are given 





Maximum exotherm temperature (Tmax) of a PMMA bone cement   
  BaSO4 content           QACM content      Tmax 
  (wt/wt%)                 (wt/wt%)             (
o
C) 
         0               5                  79 
         0              10                  75 
         5               5                  84 
         5              15                       62 
       15               0                  85 
       15              10                  78 
       15              20                  50 
       25               5                  58 
       25              15                  49 
       30               5                  88 
       30              10                  69 
 
4.1.2.  Design matrix 
Two factors (explanatory variables) were considered for their influence on the 
maximum exothermic temperature (Tmax) of a PMMA bone cement; namely, BaSO4 
content (BA) and quaternary amine co-monomer content (QU).  For each factor, 5 values 
were used; thus, there were 11 data points.  
For the RSM work (Design-Expert
®
, Version 8; Star-Ease, Inc., Minneapolis, MN), 
therefore, it was appropriate to use the two-factors, five-levels, central composite design 
matrix (rotatable option). The values of the factors used and the corresponding level for 
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each factor are given in Table 7 while, in Table 8, the 11 data points are presented both as 
coded values and as raw values.  
 
Table 7     
Factors and their levels: maximum exotherm temperature of a PMMA bone cement  
Factor Unit 
Coded levels 
-1.414 -1 0 +1 +1.414 
BaSO4 content 
(BA) 

















Design matrix and experimental results: maximum exotherm temperature of a PMMA 
bone cement   
      
Cement  
Coded values   Raw values 
Maximum  exotherm 
temperature 
BA QU BA QU                 Tmax 
      
   
(wt/wt%)         (wt/wt%) (
o
C) 
A -1.414 -1 0 5 79 
B -1.414 0 0 10 75 
C -1 -1 5 5 84 
D -1 +1 5 15 62 
E 0 -1.414 15 0 85 
F 0 0 15 10 78 
G 0 +1.414 15 20 50 
H +1 -1 25 5 58 
I +1 +1 25 15 49 
J +1.414 -1 30 5 88 









4.1.3.   Empirical relationship and regression analysis 
The second-order polynomial (regression) equation used to represent the response 
surface (Tmax) is given by 
 
                      Tmax = bo + ∑ bi Xi +∑ bij Xi Xj +∑ bii Xi
2
,                                     (8) 
 
where Xi and Xj are the two factors. 
Thus, the selected polynomial could be expressed as 
 
                Tmax = bo + b1 (BA)+ b2 (QU) + b12 (BA)(QU)  +  b11 (BA)
2  
                                      
+ b22 (QU)




where bo is the mean of the responses; b1 and b2 are the regression coefficients that 
characterize the direct effects of the factors; b12 is the regression coefficient that 
characterizes the interaction effect of the factors; and b11 and b22 are the regression 
coefficients that characterize the quadratic effects of the factors.  
With the computed values of the coefficients, it is found the quadratic models given 
above were aliased. In experimental design, when two interactions, or a main effect and 
an interaction, share the same column, and so cannot be individually analyzed, then their 
effects are termed “aliased”. Hence, the linear model is used in RSM and Eq. (9) becomes 
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                    Tmax = 91.514 -0.265(BA) – 1.858(QU)         (10)                                                                                         
 
4.1.4.     Adequacy of regression model 
Analysis of variance (ANOVA) of the regression model was performed and the 
results (Table 9) were used to examine the adequacy of the model. The desired level of 
confidence was considered to be adequate provided that 1) the calculated value of the F 
ratio of the model developed did not exceed the standard tabulated value of the F ratio 
and 2) the calculated value of the coefficient of determination (R
2
) of the developed 
relationship exceeded the standard tabulated value of the R
2
 for a desired level of 
confidence (in this case study, 0.64). 
 
Table 9    
The ANOVA results (response parameter: maximum exotherm temperature (Tmax),  
in 
o
C, of a PMMA bone cement) 
Source 
Sum of   Mean F p-value   
squares Df Square value Prob > F 
 
Model 1269.28 2 634.64 7.345 0.016 significant 
BA 91.56 1 91.56 1.060 0.333 
 
QU 1177.72 1 1177.72 13.630 0.006 
 
Residual 691.27 8 86.41    
Cor total 1960.55 10     
       
Std dev 9.296 R
2
 0.6474 
   
Mean 70.636 Adj R
2
 0.5593 
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The model F-value of 7.345 implies the model is significant because there is only a 
1.16% chance that a model F-value this large could occur due to noise. The goodness of 
fit of the model is indicated by the coefficient of determination (R
2
), which was found to 
be 0.6474, which implies that 64.74% of the experimental data were predicted by the 
model. For a good statistical model, R
2
 value should be close to 1.0. The adjusted R
2
 
value recalculates the model coefficient of determination but, this time, only the 
significant model terms were considered. The adjusted R
2
, 0.5593, was not high enough 
to confirm the significance of the model. The predicted R
2
 is 0.3801, which means that 
the model could explain 38% of the variability in predicting new Tmax observations. The 
parameter, Adeq precision, is a measure of the signal-to-noise ratio, with a value > 4 
considered desirable. In this case study, the ratio was 7.6575, which indicated an 
adequate signal. The coefficient of variation (COV), 13.16%, is low enough to indicate 
that the deviations between the experimental and the predicted values are low. All of the 
aforementioned ANOVA results show that the model (Eq. (10)) was adequate and, thus, 
may be used to navigate the design space.  
Values of "Prob > F" less than 0.0500 indicate model terms that are significant. Thus, 
in this case study, the only significant model term is QU and BA is not significant model 
term. But the model Eq. (10) is significant and was adequate and hence used as is 
 
Tmax = 91.514 -0.265(BA) - 1.858(QU)                                                         (11) 
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For a given response, the contributions of factors can be ranked from their respective 
F ratio values provided the degrees of freedom are same for all the input parameters. The 
larger the F ratio the higher is the significance. From the F ratio values (Table 9), it is 
seen that QU exerts a greater influence on Tmax than does BA.  
4.1.5.    Residuals and correlation exercises 
The normal probability plot of the residuals for Tmax is not perfectly linear (Fig. 11), 
indicating that the errors (residuals) are not distributed normally. There are extreme 
positive and negative residuals and, hence, this distribution is “heavy tailed”. The 
relationship between the sample percentiles and theoretical percentiles is not linear and, 
hence, the condition that the error terms are normally distributed is not met. The match 
between the predicated and the experimental maximum exothermic temperature Tmax 
values is not very good (Fig. 12).  
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Fig. 11. The normal probability plot of the maximum exotherm temperature results for a 
PMMA bone cement. 
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Fig. 12.  The correlation plot of the maximum exothermic temperature (Tmax) results for a 









4.1.6.   Optimization exercise 
To obtain the optimum combination for getting cement the minimum value of Tmax, 
response surface, contour, and desirability plots were developed for the proposed model 
that contained only the significant coefficients (Eq. (11)). A contour plot was produced to 
display the regions of the optimal factor settings. Either the response surface plot or the 
contour plot may be used to predict the response (minimum value of Tmax) for any zone 
of the experimental domain. As shown on the surface response plot (Fig. 13A), the 
desired optimum is the minimum value. After identifying the stationary point in a contour 
plot, it has to be determined if it is the maximum, minimum, target, or saddle point. An 
analysis of the response surface and contour plots (Figs. 13A and B) found that the 
indicated minimum value (47.62
o 
C) has a desirability equal to 1.000 (Fig 13C). This 


















































                     
 
 
Fig. 13. The response surface plot (A), the contour plot (B) and the desirability plot (C) 
for the influence of barium sulfate content (BA) and quaternary amine comonomer 






4.2.  Case Study #2:   Residual monomer content of a PMMA bone cement  
4.2.1.   Experimental details 
A radiolucent cement powder was used, while the liquid was that in a commercially-




; Medtronic Spinal & Biologics, 
Memphis, TN, USA) but modified by addition of a quaternary amine co-monomer 
(QACM). The cement powder and liquid were mixed in a polyethylene bowl that was 
open to the laboratory atmosphere. 
7 days after preparation of the fully cured cement specimens, a sample (mass 1 g) was 
cut from a specimen and  dissolved in a deuterated chloroform solution (5% w/v) using 
tetramethylsilane as an internal reference. Then the proton nuclear magnetic resonance 
(
1
H-NMR) spectra of the solution was obtained. The residual monomer content (RMC) of 
the cement was calculated using the expression  
 
                                          RMC = 100 (AMMA)/(APMMA + AMMA)%,   (12) 
 
where AMMA is the area in the peak, in the spectrum, that was assigned to the methoxyl 
protons of the monomer, MMA and QACM (where included) and APMMA is the sum of 
the areas of the peaks, in the spectrum, that were assigned to the methoxyl protons of the 






Residual monomer content (RMC) of a PMMA bone cement   
  BaSO4 content        Quaternary amine           RMC 
             comonomer content 
  (wt/wt%)               (wt/wt%)                (%) 
         0              5                 2.8 
         0             10                3.5 
         5              5                 2.6 
         5             15                    5.1 
       15              0                 1.3 
       15             10                 4.0 
       15             20                 5.4 
       25              5                 2.4 
       25             15                 5.8 
       30              5                3.4 
       30             10                4.7 
 
4.2.2.  Design matrix 
Two factors (explanatory variables) were considered for their influence on residual 
monomer content (RMC) of a PMMA bone cement; namely, BaSO4 content (BA) and 
quaternary amine comonomer content (QU).  For each factor, 5 values were used; thus, 




For the RSM work (Design Expert
®
, Version 8), therefore, it was appropriate to use 
the two-factors, five-levels, central composite design matrix (rotatable option). The 
values of the factors used and the corresponding level for each factor are given in Table 
11 while, in Table 12, the 11 data points are presented both as coded values and as raw 
values.  
 
Table 11     
Factors and their levels: residual monomer content of a PMMA bone cement    
Factor Unit 
Coded levels 
-1.414 -1 0 +1 +1.414 
BaSO4 Content 
(BA) 
















Table 12  
Design matrix and experimental results; residual monomer content of a PMMA bone 
cement  
    




BA QU BA QU (RMC) 
      
   
(wt/wt%) 
        
(wt/wt%) (%) 
A -1.414 -1 0 5 2.8 
B -1.414 0 0 10 3.5 
C -1 -1 5 5 2.6 
D -1 +1 5 15 5.1 
E 0 -1.414 15 0 1.3 
F 0 0 15 10 4.0 
G 0 +1.414 15 20 5.4 
H +1 -1 25 5 2.4 
I +1 +1 25 15 5.8 
J +1.414 -1 30 5 3.4 
K +1.414 0 30 10 4.7 
 
4.2.3.   Empirical relationship and regression analysis 
The second-order polynomial (regression) equation used to represent the response 
surface for RMC is given by 
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                             RMC = bo + ∑ bi Xi +∑ bij Xi Xj +∑ bii Xi
2
,                                                          (13) 
                         
 
where Xi and Xj are the two factors. 
Thus, the selected polynomial could be expressed as 
 
                        RMC = bo + b1 (BA)+ b2 (DE) + b12 (BA)(DE)  +  b11 (BA)
2  








where bo is the mean of the responses; b1 and b2 are the regression coefficients that 
characterize the direct effects of the factors; b12 is the regression coefficient that 
characterizes the interaction effect of the factors; and b11 and b22 are the regression 
coefficients that characterize the quadratic effects of the factors.  
With the computed values of the coefficients, it is found the quadratic models given 
above were aliased. In experimental design, when two interactions, or a main effect and 
an interaction, share the same column, and so cannot be individually analyzed, then their 
effects are termed “aliased”. Hence, the linear model is used in RSM and Eq. (14) 
becomes 
 
                      RMC = 1.3107 - 0.0246(BA) + 0.2252(QU)         (15)                                                                                                                                                                   
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4.2.4.     Adequacy of regression model 
Analysis of variance (ANOVA) of the regression model was performed and the 
results (Table 13) were used to examine the adequacy of the model. The desired level of 
confidence was considered to be adequate provided that 1) the calculated value of the F 
ratio of the model developed did not exceed the standard tabulated value of the F ratio 
and 2) the calculated value of the coefficient of determination (R
2
) of the developed 
relationship exceeded the standard tabulated value of the R
2
 for a desired level of 
confidence (in this study, 0.906). 
 
Table 13    
The ANOVA results (response: parameter: residual monomer content (RMC), in %, of a 
PMMA bone cement) 
Source Sum of  Mean F p-value  
squares df square value Prob > F  
Model 18.08 2 9.04 38.77 < 0.0001 significant 
   BA 0.79 1 0.79 3.38 0.1033 
 
  QU 17.29 1 17.29 74.17 < 0.0001 
 
Residual 1.86 8 0.23 
   
Cor total 19.94 10 
     
      
Std dev 0.48 R2 0.9065    
Mean 3.73 Adj R2 0.8831    









The model F-value of 38.77 implies the model is significant because there is only a 
0.01% chance that a model F-value this large could occur due to noise. The goodness of 
fit of the model is indicated by the coefficient of determination (R
2
), which was found to 
be 0.9065, which implies that 90.65% of the experimental data were predicted by the 
model. The adjusted R
2
 value recalculates the model coefficient of determination but, this 
time, only the significant model terms were considered. The adjusted R
2
, 0.8831, was 
high enough to confirm the high significance of the model. The predicted R
2
 is 0.7847, 
which means that the model could explain 78% of the variability in predicting new RMC 
observations is in reasonable agreement with the adjusted R
2
 of 0.8831. The parameter, 
Adeq precision, is a measure of the signal-to-noise ratio, with a value > 4 considered 
desirable. In this case study, the ratio was 17.863, which indicated an adequate signal. 
The coefficient of variation (COV), 12.95%, is low enough to indicate that the deviations 
between the experimental and the predicted values are low. All of the aforementioned 
ANOVA results show that the model (Eq. (15)) was adequate and, thus, may be used to 
navigate the design space.  
Values of "Prob > F" less than 0.0500 indicate model terms are significant. Thus, in 
this case study, the only significant model term is QU and BA is non-significant term. 
Thus, in this case study, the model Eq. (15) was adequate and used as is 
 
 RMC = 1.3107 - 0.0246(BA) + 0.2252(QU)              (16) 
 
 81 
For a given response, the contributions of factors can be ranked from their respective 
F ratio values provided the degrees of freedom are same for all the input parameters. The 
larger the F ratio the higher is the significance. From the F ratio values (Table 13), it is 
seen that QU exerts a greater influence on RMC than does BA.  
4.2.5.    Residuals and correlation exercises 
The normal probability plot of the residuals is approximately linear (Fig. 14), 
indicating that the errors (residuals) are approximated distributed normally. By default, 
the residuals are studentized; that is, they are converted to a standard deviation scale. 
Ideally, the normal plot of residuals is a straight line, indicating no abnormalities. The 
data do not have to match up perfectly with the line. A good rule of thumb is called the 
‘fat pencil” test. In this case, you can easily put a fat pencil over the line and cover up all 
the data points, and, hence, the data in Fig. 14 is sufficiently normal. The match between 
the predicated and the experimental values is very good (Fig. 15). It is observed there is 





















4.2.6.   Optimization exercise 
To obtain the optimum combination for getting minimum RMC, response surface, 
contour, and desirability plots were developed for the proposed model that contained only 
the significant coefficients (Eq. (16)). A contour plot is produced to display the regions of 
the optimal factor settings. Either the response surface plot or the contour plot can be 
used to predict the response (minimum RMC) for any zone of the experimental domain. 
As shown on the surface response plot, the desired optimum is the minimum value     
(Fig. 16A). After identifying the stationary point in a contour plot, it has to be determined 
if it is the maximum, minimum, target, or saddle point. An analysis of the response 
surface and contour plots (Figs. 16A and B) found that the indicated minimum RSM 
(1.809%) has a desirability of 1.00 (Fig. 16C). This minimum RMC is obtained when BA 
= 20.25 wt/wt% and QU = 0 wt/wt%. It is noted that the desirability is equal to 0.886 
and, hence, the model may not be good enough to accurately predict the minimum RMC 














































Fig. 16. The response surface plot (A), the contour plot (B) and the desirability plot (C) 
for the influence of barium sulfate content (BA) and quaternary amine comonomer 








4.3.    Case Study #3:  Degradability of a PMMA bone cement   
4.3.1.   Experimental details 





; Medtronic Spinal & Biologics, Memphis, TN, USA). The powder was modified by 
the addition of finely ground spherical glass beads that had its surface treated with 0.2 
wt/wt  methacryloxy propyl trimethoxy silane (mean diameter of glass powder = 3.2 
m) and finely-ground chitosan particles (diameter: 60-600 m). The cement powder 
and liquid were mixed in a polyethylene bowl that was open to the laboratory 
atmosphere. 
For this test, a VB augmentation model was used and it comprised a polyurethane 
(PU) foam (Last-a-Foam

FR-; Polymer Tooling Systems, Inc., Exton, PA, USA; 
density = 128 kg m
-3
) cube (26 mm sides) into which a centrally-located through-
thickness cylindrical hole (diameter, 14 mm) was drilled. The density of this 
commercially-available material is the same as that suggested for PU foam that models 
cancellous bones with severe osteoporosis [126].  The cement bolus was injected into the 
cylindrical hole, which represented the fracture zone in a VB. The volume of cement used 
in VP or BKP is in the range of 3.5-8.0 mL  [127, 128]. With the mean volume of VBs 
that are commonly augmented using VP or BKP (T6–L5) being 29.4 mL [129], the range 
of the computed cement volume ratio (Cr) is, thus, 13-27 %. The value of Cr used in the 
present study (23%) is within this range. 
The cube was then immersed in a beaker that contained 1X phosphate buffered saline, 
after which the beaker was covered and placed in an incubator (Model 610; Fisher 
Scientific, Inc, Fair Lawn, NJ) that was set at 37
o
 C. After 10 weeks, the cube was 
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removed and then imaged using microcomputed tomography. The residual material 
volume fraction (RMVF) was calculated as the ratio of the volume of residual cement to 
the volume of the cement cylinder in a region of interest.  After that, degradability of the 
cement was computed thus 
 
                                    Degradability =    100 (1– RMVF)%    (17) 
 
For each of the five cements, the test was run four times. The results are given in      
Table  14. 
 
Table 14 
Degradability of a PMMA bone cement  
Cement PMMA            Bioactive glass         Chitosan           Degradability                   
            powder           particles           particles  
        content           content            content 
       (wt/wt%)          (wt/wt%)           (wt/wt%)     (%)          
CONTROL      100           0        0    2.05 ± 0.09 
EXPCI        65         31        4     8.63 ± 0.81 
EXPCII       51         41        8   19.30 ± 1.24 
EXPCIII      40         50            10   26.00 ± 2.16 





4.3.2.  Design matrix 
Three factors (explanatory variables) were considered for their influence on 
degradability; namely, PMMA powder content (A), bioactive glass particles content (B) 
and chitosan particles content (C).  This is a mixture-type experiment in which the factors 
are the constituents of the cement powder (in wt/wt%). The constraint on these factors is 
that their amounts must add up to 100 wt/wt% and, as such, the levels of the factors 
cannot be chosen independently.  
For the RSM work (Design Expert
®
, Version 8), therefore, it was appropriate to use 
the three-factors, five-levels, mixture experiment design (IV optimal option). The values 
of the factors used and the corresponding level for each factor are given in Table 15 
while, in Table 16, the 20 data points are presented both as coded values and as raw 
values.  
In mixture design, the purpose of the experiment is to model the blending surface 
with some form of mathematical equation in order to achieve three objectives. First, 
predictions of the response for any mixture or combination of the powder constituents 
can be made empirically. Second, some measure of the influence on the response of each 
component singly and in combination with other components can be obtained. Third, in 
all cases, the model has to follow the restriction where the amounts of the constituents 






Factors and their levels: degradability of a PMMA bone cement 
Factor Unit 
  Coded levels 
-1.68 -1 0 +1 +1.68 
PMMA powder 
content  (A) 
wt./wt.% 31 41 51 65 100 
Bioactive glass 
particles content (B) 
wt./wt.% 0 31 41 50 57 
Chitosan particles 
content (C) 



































Design matrix and experimental results: degradability of a PMMA bone cement  
  Cement  





A B C A B C                                  
  Control 1.000 0.000 0.000 100  0 0 2.140 
  Control 1.000 0.000 0.000 100 0 0 2.095 
  Control 1.000 0.000 0.000 100 0 0 2.005 
  Control 1.000 0.000 0.000 100 0 0 1.960 
  EXPC I 0.493 0.449 0.058 65 31 4 9.440 
  EXPC I 0.493 0.449 0.058 65 31 4 9.035 
  EXPC I 0.493 0.449 0.058 65 31 4 8.225 
  EXPC I 0.493 0.449 0.058 65 31 4 7.820 
  EXPC II 0.290 0594 0.116 51 41 8 20.540 
  EXPC II 0.290 0594 0.116 51 41 8 19.920 
  EXPC II 0.290 0594 0.116 51 41 8 18.680 
  EXPC II 0.290 0594 0.116 51 41 8 18.060 
  EXPC III 0.130 0.725 0.145 40 50 10 28.160 
  EXPC III 0.130 0.725 0.145 40 50 10 27.080 
  EXPC III 0.130 0.725 0.145 40 50 10 24.920 
  EXPC III 0.130 0.725 0.145 40 50 10 23.840 
  EXPC IV 0.000 0.826 0.174 31 57 12 39.790 
  EXPC IV 0.000 0.826 0.174 31 57 12 38.320 
  EXPC IV 0.000 0.826 0.174 31 57 12 35.380 







4.3.3.   Empirical relationship and regression analysis 
The second-order polynomial (regression) equation used to represent the response 
surface (Degradability (D)) is given by 
 
                      D  =  ∑b i Xi  +  ∑∑bij  Xi  Xj,                                                      (18) 
 
where Xi and Xj are the amount of cement powder constituents. 
Thus, the selected polynomial could be expressed as 
 
                       D = b1 (A)+ b2 (B) + b3 (C) + b12 (A)(B)  +  b13 (A)(C) +
 
b23 (B)(C),  




where b1,  b2, and b2 are the regression coefficients that characterize the direct effects of 
the factors; b12, b13, and b23 are the regression coefficients that characterize the interaction 
effect of the factors.  
It is recommended to select the highest order polynomial where the additional terms 
are significant and the model is not aliased. The quadratic model and higher are aliased. 
Hence, with the computed values of the coefficients, Eq. (19) becomes 
 
                        D  = 0.016(A) – 0.381(B) + 4.608(C)                                                                     (20) 
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4.3.4.     Adequacy of regression model 
Analysis of variance (ANOVA) of the regression model was performed and the 
results (Table 17) were used to examine the adequacy of the model. The desired level of 
confidence was considered to be adequate provided that 1) the calculated value of the F 
ratio of the model developed did not exceed the standard tabulated value of the F ratio 
and 2) the calculated value of the coefficient of determination (R
2
) of the developed 
relationship exceeded the standard tabulated value of the R
2
 for a desired level of 
confidence (in this case study, 0.96). 
 
Table 17    
The ANOVA results (response parameter: degradability (D), in %, of a PMMA bone 
cement 
Source  Sum of 
squares 
  





Prob > F  
 
Model  2969.512 2 1484.756 218.15 < 0.0001 significant 
Linear 
Mixture  
2969.512 2 1484.756 218.15 < 0.0001  
Residual 115.7056 17 6.806211    
Lack of fit 76.92809 2 38.46404 14.88 0.0003 significant 
Pure error 38.7775 15 2.585167    
Cor total 3085.218 19     
       
Std dev  2.61 R
2
 0.9625 
Mean  18.57 Adj R
2
 0.9581 
COV (%)  14.05 Pred R
2
 0.9525 
  Adeq precision            32.1406 
 
       
 95 
The model F-value of 218.15 implies the model is significant because there is only a 
0.01% chance that a model F-value this large could occur due to noise. The goodness of 
fit of the model is indicated by the coefficient of determination (R
2
), which was found to 
be 0.9625, which implies that 96.25% of the experimental data were predicted by the 
model. The adjusted R
2
 value recalculates the model coefficient of determination but, this 
time, only the significant model terms were considered. The adjusted R
2
, 0.9581, was 
high enough to confirm the high significance of the model. The predicted R
2
 is 0.9525, 
which means that the model could explain 95% or more of the variability in predicting 
new degradability observations. This is in excellent agreement with the adjusted R
2
 of 
0.9581. The parameter, Adeq precision, is a measure of the signal-to-noise ratio, with a 
value > 4 considered desirable. In this case study, the ratio was 32.1406, which indicated 
an adequate signal. The coefficient of variation (COV), 14.05%, is low enough to 
indicate that the deviations between the experimental and the predicted values are low. 
The "lack of fit F-value" of 14.88 implies the lack of fit is significant. There is only 
0.03% chance that a "lack of fit F-value" this large could occur due to noise. Significant 
lack of fit is bad because we want the model to fit. All of the aforementioned ANOVA 
results show that the model (Eq. (20)) was adequate and, thus, may be used to navigate 
the design space.  
For a model term, a value of Prob>F less than 0.0500 indicates that it is significant. 
Thus, in this case study, the linear terms A, B, and C are the significant model terms. In 
that case, Eq. (20) is of the same order as of equation (19) with no interaction term: 
 
D  = 0.016(A) – 0.381(B) + 4.608(C)                                                                  (21) 
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For a given response, the contributions of factors can be ranked from their respective 
F ratio values provided the degrees of freedom are same for all the input parameters. The 
larger the F ratio the higher is the significance. From the F ratio values (Table 17), it is 
seen that the mixture of A, B, and C exerts the greatest influence on degradability.  
4.3.5.    Residuals and correlation exercises 
The residuals from the least squares fit play an important role in judging model 
adequacy. The normal probability plot of the residuals for D is linear (Fig. 17), indicating 
that the errors are distributed normally. The match between the predicted and the 
experimental D values is very good (Fig. 18). This helps us to assess the validity of our 
model. Fig. 17 is a normal probability plot of the studentized residuals from the quadratic 
mixture model. This plot is satisfactory for a mixture experiment because the points in a 
mixture design can have substantial differences in their leverage values. As shown, the 
residuals plot is, approximately a straight line; thus, the normality assumption is satisfied. 
In this normal probability plot, there are no data point that can be considered as outliers. 
Fig. 18 shows a plot of the values of the observed response versus the predicted values. 
The pairs lie closely along a straight line (the straight line in the graph is a result of a 























4.3.6.   Optimization exercise 
To obtain the optimum combination for maximizing degradability (D) of the cement, 
response surface, contour, and desirability plots were developed for the proposed model 
that contained only the significant coefficients (Eq. (21)). A contour plot is produced to 
display the regions of the optimal factor settings. Either the response surface plot or the 
contour plot can be used to predict the response (degradability) for any zone of the 
experimental domain. The right-hand tip of the response plot (Fig. 19A) shows the 
maximum degradability (in %). After identifying the stationary point in a contour plot, it 
has to be determined if it is a maximum, minimum, or saddle point. An analysis of the 
response surface and contour plots (Figs. 19A and B) found that a number of maximum 
degradability RSM solutions are possible and this needs actual testing to verify the result, 
based on highest desirability the maximum then was estimated to be 41.19%. The 
corresponding parameters that yielded this maximum value were  A = 50.90 wt/wt%, B = 
37.25 wt/wt%, and C = 11.85 wt/wt%. The desirability factor for the optimum solution is 













































Fig. 19.  The response surface plot (A), contour plot (B) and desirability plot (C) for 
influence of PMMA cement powder content, bioactive glass particles content, and 





4.4.  Case study #4:  Injectability of a calcium phosphate cement  
4.4.1.    Experimental details 
The powder constituents of the cement were CaCO3, DCPA, and TCP, while the 
liquid was an aqueous solution of poly (ethylene glycol) (PEG). The powder and liquid 
were mixed, with a spatula, in a glass dish, until a paste was obtained. 
The cement powder and liquid was mixed in a 10-mL disposable syringe fitted with 
an 11-gage needle (1.1 mm x 30 mm) needle for 45 s. The assembly was then placed in a 
universal materials testing machine. After 2 min, a force of 300 N was applied to the 
plunger of the syringe, at a crosshead displacement rate of 10 mm min
-1
, for 3 min, 
thereby extruding the paste through the needle. The injectability was calculated using the 
expression  
 
      Injectability = 100     (mass of cement extruded from the syringe)       %                (22) 
        (original mass of cement paste loaded in the syringe)    
                                  
 










Injectability of a calcium phosphate cement  
  PEG content          PLR      Injectability 
  (wt/wt%)         (g mL
-1
)          (%) 
         0              2.0      50.6 ± 1.52 
       10              2.0            76.4 ± 4.54 
       20              2.0      96.1 ± 3.57 
         0              3.0      18.7 ± 0.46 
       10              3.0     40.3 ± 2.20 
       20              3.0      62.6 ± 2.80 
         0              3.5      14.8 ± 0.32 
       10              3.5      26.7 ± 1.48 
       20              3.5      44.9 ± 2.45 
 
4.4.2.  Design matrix 
Two factors (explanatory variables) were considered for their influence on 
injectability; namely, PEG content (PC) and powder-to-liquid ratio (PLR).  For each 
factor, three values were used; thus, there were 27 data points.  
For the RSM work (Design Expert
®
, Version 8), therefore, it was appropriate to use 
the two-factors, three-levels, central composite design matrix face centered option (CCD 
option). The values of the factors used and the corresponding level for each factor are 
given in Table 19 while, in Table 20, the 27 data points are presented both as coded 
values and as raw values.  
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Table 19     
Factors and their levels: injectability of a calcium phosphate cement 
Factor Unit 
Coded levels 
-1 0 +1 























Design matrix and experimental results: injectability of a calcium phosphate cement  
      Cement  
Coded values   Raw values Injectability          
(%) 
 
PC PLR        PC 
   (wt/wt%) 
       PLR 
        (g mL
-1
) 
A -1 -1 0 2.0 49.08 
 
A -1 -1 0 2.0 50.60 
A -1 -1 0 2.0 52.12 
B 0 -1 10 2.0 71.86 
B 0 -1 10 2.0 76.40 
B 0 -1 10 2.0 80.94 
C +1 -1 20 2.0 92.53 
C +1 -1 20 2.0 96.10 
C +1 -1 20 2.0 99.67 
D -1 0 0 3.0 18.24 
D -1 0 0 3.0 18.70 
D -1 0 0 3.0 19.16 
E 0 0 10 3.0 38.10 
E 0 0 10 3.0 40.30 
E 0 0 10 3.0 42.50 
F +1 0 20 3.0 59.80 
F +1 0 20 3.0 62.60 
F +1 0 20 3.0 65.40 
G -1 +1 0 3.5 14.48 
G -1 +1 0 3.5 14.80 
G -1 +1 0 3.5 15.12 
H 0 +1 10 3.5 25.22 
H 0 +1 10 3.5 26.70 
H 0 +1 10 3.5 28.18 
I +1 +1 20 3.5 42.45 
I +1 +1 20 3.5 44.90 









4.4.3.   Empirical relationship and regression analysis 
The second-order polynomial (regression) equation used to represent the response 
surface (I) is given by 
 
             I = bo + ∑ bi Xi +∑ bij Xi Xj +∑ bii Xi
2
,                               (23)
  
 
where Xi and Xj are the two factors. 
Thus, the selected polynomial could be expressed as 
 









where bo is the average of the responses; b1 and b2 are the regression coefficients that 
characterize the direct effects of the factors; b12 is the regression coefficient that 
characterizes the interaction effect of the factors; and b11 and b22 are the regression 
coefficients that characterize the quadratic effects of the factors.  
With the computed values of the coefficients, Eq. (24) becomes 
 
I = 150.8 + 3.24(PC) – 63.87(PLR) - 0.45(PC)(PLR) + 0.0015(PC)
2
  
            + 6.91(PLR)
2 
              (25)                                                                                                                                                                
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4.4.4.     Adequacy of regression model 
Analysis of variance (ANOVA) of the regression model was performed and the 
results (Table 21) were used to examine the adequacy of the model. The desired level of 
confidence was considered to be adequate provided that 1) the calculated value of the F 
ratio of the model developed did not exceed the standard tabulated value of the F ratio 
and 2) the calculated value of the coefficient of determination (R
2
) of the developed 
relationship exceeded the standard tabulated value of the R
2
 for a desired level of 

















Table 21    
ANOVA results (response parameter: injectability (I), in %, of a calcium phosphate 
cement) 
Source  Sum of 
squares  
df  Mean 
square  
F Value  p-value 
Prob >F  
 
Model  17358.97  5  3471.79  324.47  < 0.0001  significant 
PC  7282.36  1  7282.36  680.60 < 0.0001 
 
PLR  9343.44  1  9343.44  873.23 < 0.0001 
 








  69.09  1  69.09  6.45 0.019 
 
Residual  224.69  21  10.70  
   
Lack of fit  110.99  3  36.699  5.85  0.0057  significant  
Pure error  113.70 18  6.32 
   
Cor total  17583.67 26      




 0.9872  




 0.9841  
COV (%)  6.83 Pred R
2
 0.9790  
    
  Adeq precision  55.871 
 
 
The model F-value of 324.47 implies the model is significant because there is only a 
0.01% chance that a model F-value this large could occur due to noise. The goodness of 
fit of the model is indicated by the coefficient of determination (R
2
), which was found to 
be 0.9872, which implies that 98.72% of the experimental data were predicted by the 
model. For a good statistical model, R
2




value recalculates the model coefficient of determination but, this time, only the 
significant model terms are considered. The adjusted R
2
, 0.9841, was high enough to 
confirm the high significance of the model. The predicted R
2
 is 0.9790, which means that 
the model could explain 97.9% of the variability in predicting new injectability 
observations. The parameter, Adeq precision, is a measure of the signal-to-noise ratio, 
with a value > 4 considered desirable. In this case study, the ratio was 55.87, which 
indicated an adequate signal. The coefficient of variation (COV), 6.82%, is low enough 
to indicate that the deviations between the experimental and the predicted I values are 
low. All of the aforementioned ANOVA results show that the model (Eq. (25)) was 
adequate and, thus, may be used to navigate the design space. The "lack of fit F-value" of 
110.99 implies the lack of fit is significant. There is only a 0.57% chance that a "lack of 
fit F-value" this large could occur. Significant lack of fit is bad because we want the 
model to fit. Because the p value is smaller than the significance level α = 0.05, there is 
sufficient evidence at the α = 0.05 level to conclude that there is lack of fit.   
For a model term, a value of Prob>F less than 0.0500 indicates that it is significant. 
Thus, in this case study, PC, PLR, (PLR)
2
 and (PC)(PLR) are each a significant model 
term but (PC)
2
 is a non-significant term. Thus the model is acceptable to navigate the 
design space and Eq. (25) can be used as is 
 
                 I = 150.8 + 3.24(PC) – 63.87(PLR) - 0.45(PC)(PLR) + 0.0015(PC)
2
 
                                 + 6.91(PLR)
2 
                                                                                                                                           (26) 
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For a given response, the contributions of factors can be ranked from their respective 
F ratio values provided the degrees of freedom are same for all the input parameters. The 
larger the F ratio the higher is the significance. From the F ratio values (Table 21), it is 
seen that PLR exerts the greater influence on I. The interaction effects (PC)(PLR) and the 
square effect (PLR)
2
 exert less significance compared to the aforementioned main terms.  
4.4.5.    Residuals and correlation exercises 
The normal probability plot of the residuals for I is linear (Fig. 20), indicating that the 
errors are distributed normally. The match between the predicated and the experimental I 
values is very good (Fig. 21). This helps us to assess the validity of our model.  As shown 
on the plot, the standardized residual larger than 3 is considered as outliers. In this normal 
probability plot, there is no data point that can be considered as outliers. But for some 
value of I near residual value of -1, it is observed the data points deviate from the straight 
line compared to the other set of data shown around the straight line. Fig. 21 shows the 
actual value in the horizontal axis where three values are shown for each predicted value.  
This is given from the dataset where the minimum, mean, and maximum values are 





















4.4.6.   Optimization exercise 
To obtain the optimum combination for maximizing I of the cement, response 
surface, contour, and desirability plots were developed for the proposed model that 
contained only the significant coefficients (Eq. (26)). A contour plot is produced to 
display the regions of the optimal factor settings. Either the response surface plot or the 
contour plot can be used to predict the response (I value) for any zone of the experimental 
domain. The right-hand tip of the response plot (Fig 22A) shows the maximum I value 
measured in percentage (%). After identifying the stationary point in a contour plot, it has 
to be determined if it is the maximum, minimum, or saddle point. An analysis of the 
response surface and contour plots (Fig. 22A and B) found that the maximum I to be 
98.1%. The corresponding parameters that yielded this maximum value were PC = 20 
wt/wt% and PLR = 2.0 g mL
-1
. The desirability factor for the optimum solution is 0.981 











































Fig. 22. The response surface plot (A), contour plot (B) and desirability plot (C) for 










4.5.    Case Study #5:  Final setting time of a calcium phosphate cement  
4.5.1. Experimental details 
The powder constituents of the cement were CaCO3, DCPA, and TCP, while the 
liquid was an aqueous solution of poly (ethylene glycol) (PEG). The powder and liquid 
were mixed, with a spatula, in a glass dish, until a paste was obtained. 
The final setting times were determined using the Gillmore needle method (per 
ASTM C266-99 [57]).The apparatus comprised a weighted needle (diameter and weight  
=1.06 mm and 453.6 g, respectively). After mixing the cement powder and liquid, the 
paste was poured into a PTFE mold (nominal diameter and height = 6 mm and 12 mm, 
respectively), held at 37
o 
C. The final setting time was denoted as the time taken for the 
curing cement to bear the weight of the needles without any appreciable indentation to its 
surface. The surface of the specimen was observed visually every 30 s, until it was 
deemed that the indentation was negligible. Each test was run in triplicate. The results are 












Final setting time of a calcium phosphate cement  
  PEG content          PLR                      Final setting time 
  (wt/wt%)         (g mL
-1
)           (min) 
         0              2.0       26.3 ± 0.8 
       10             2.0                 35.4 ± 1.4 
       20              2.0       42.1 ± 1.3 
         0              2.5       12.9 ± 0.3 
       10             2.5      24.6 ± 0.7 
       20              2.5       36.3 ± 1.6 
         0              3.5         4.8 ± 0.2 
       10              3.5         8.6 ± 0.3 
       20              3.5       13.1 ± 0.30 
 
4.5.2.  Design matrix 
Two factors (explanatory variables) were considered for their influence on final 
setting time (F); namely, PEG content (PC) and powder-to-liquid ratio (PLR).  For each 
factor,  9 values were used; thus, there were 27 data points.  
      For the RSM work (Design Expert
®
, Version 8), therefore, it was appropriate to use 
the two-factors, three-levels, central composite design matrix (CCD). The values of the 
factors used and the corresponding level for each factor are given in Table 23 while, in 
Table 24, the 27 data points are presented both as coded values and as raw values.  
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Table 23     
Factors and their levels: final setting time of a calcium phosphate cement 
Factor Unit 
Coded levels 
-1 0 +1 






















Table 24  
Design matrix and experimental results: final setting time of a calcium phosphate cement  
      
Cement  
Coded values   Raw values Final setting time 
PC PLR PC PLR F 
      
   
(wt/wt%)    (g mL
-1
) (min) 
A -1 -1 0 2.0 27.13 
A -1 -1 0 2.0 26.32 
A -1 -1 0 2.0 25.51 
B 0 -1 10 2.0 36.86 
B 0 -1 10 2.0 35.43 
B 0 -1 10 2.0 34.00 
C 1 -1 20 2.0 43.45 
C 1 -1 20 2.0 42.11 
C 1 -1 20 2.0 40.77 
D -1 0 0 2.5  13.25 
D -1 0 0 2.5  12.94 
D -1 0 0 2.5  12.63 
E 0 0 10 2.5 25.29 
E 0 0 10 2.5 24.60 
E 0 0 10 2.5 23.91 
F 1 0 20 2.5 37.92 
F 1 0 20 2.5 36.33 
F 1 0 20 2.5 34.74 
G -1 1 0 3.5   4.97 
G -1 1 0 3.5   4.80 
G -1 1 0 3.5  4.63 
H 0 1 10 3.5   8.88 
H 0 1 10 3.5   8.63 
H 0 1 10 3.5   8.38 
I 1 1 20 3.5 13.43 
I 1 1 20 3.5 13.14 







4.5.3.   Empirical relationship and regression analysis 
The second-order polynomial (regression) equation used to represent the response 
surface (final setting time (F)) is given by 
 
         F = bo + ∑ bi Xi +∑ bij Xi Xj +∑ bii Xi
2
,                                       (27)
  
 
where Xi and Xj are the two factors. 
Thus, the selected polynomial could be expressed as 
 









where bo is the average of the responses; b1 and b2 are the regression coefficients that 
characterize the direct effects of the factors; b12 is the regression coefficient that 
characterizes the interaction effect of the factors; and b11 and b22 are the regression 
coefficients that characterize the quadratic effects of the factors.  
With the computed values of the coefficients, it is found the cubic and above models 
were aliased. In experimental design, when two interactions, or a main effect and an 
interaction, share the same column, and so cannot be individually analyzed, then their 
effects are termed “aliased”. Two factors interaction 2FI model is suggested to best fit the 
model. Hence, the 2FI model is used in RSM and Eq. (28) becomes 
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            F = 51.502  + 1.646(PC) – 13.770(PLR) - 0.320(PC)(PLR)                 (29) 
4.5.4.     Adequacy of regression model 
Analysis of variance (ANOVA) of the regression model was performed and the 
results (Table 25) were used to examine the adequacy of the model. The desired level of 
confidence was considered to be adequate provided that 1) the calculated value of the F 
ratio of the model developed did not exceed the standard tabulated value of the F ratio 
and 2) the calculated value of the coefficient of determination (R
2
) of the developed 
relationship exceeded the standard tabulated value of the R
2
 for a desired level of 













Table 25    
The ANOVA results (response parameter: final setting time (F), in min, of a calcium 
phosphate cement) 
Source 
Sum of   Mean F p-value   
squares df square value Prob > F 
 
Model 4226.24 3 1408.75 252.63 < 0.0001 significant 
  PC 1035.75 1 1035.75 185.74 < 0.0001 
 
  PLR 3025.33 1 3025.33 542.52 < 0.0001 
 
(PC)(PLR) 71.84 1 71.84 12.88 0.0016 
 
Residual 128.26 23 5.58 
   
Lack of fit 112.71 5 22.54 26.10 < 0.0001 significant 
Pure error 15.54 18 0.86 
   
Cor total 4354.50 26 
    
Std dev 2.36 R
2
 0.9705 
   
Mean 22.70 Adj R2 0.9667 
   
COV (%) 10.40 Pred R2 0.9604 





      
 
The model F-value of 252.63 implies the model is significant because there is only a 
0.01% chance that a model F-value this large could occur due to noise. The goodness of 
fit of the model is indicated by the coefficient of determination (R
2
), which was found to 
be 0.9705, which implies that 97.05% of the experimental data were predicted by the 
model. The adjusted R
2
, 0.9667, was high enough to confirm the high significance of the 
model. The predicted R
2
 is 0.9604, which means that the model could explain 96% of the 
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variability in predicting new final setting time observations. The parameter, Adeq 
precision, is a measure of the signal-to-noise ratio, with a value > 4 considered desirable. 
In this case study, the ratio was 44.85, which indicated an adequate signal. The 
coefficient of variation (COV), 10.40%, is low enough to indicate that the deviations 
between the experimental and the predicted I values are low. All of the aforementioned 
ANOVA results show that the model (Eq. (29)) was adequate and, thus, may be used to 
navigate the design space. The "lack of fit F-value" of 22.54 implies the lack of fit is 
significant. There is only a 0.01% chance that a "lack of fit F-value" this large could 
occur. Significant lack of fit is bad because we want the model to fit. Because the  p-
value is smaller than the significance level α = 0.05, there is sufficient evidence at the α = 
0.05 level to conclude that there is lack of fit.   
For a model term, a value of Prob>F less than 0.0500 indicates that it is significant. 
Thus, in this case study, PC, PLR and (PC)(PLR) are the only significant model terms 
and square terms are not significant. In that case, Eq. (28) reduces to 
 
F = 51.502  + 1.646(PC) – 13.770(PLR) - 0.320(PC)(PLR)                 (30) 
 
For a given response, the contributions of factors can be ranked from their respective 
F ratio values provided the degrees of freedom are same for all the input parameters. The 
larger the F ratio the higher is the significance. From the F ratio values (Table 3), it is 
seen that PLR exerts a greater influence on the final setting time than does PC but the 
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interaction term (PC)(PLR) exerts far less influence on the final setting time compared to 
the main terms, PC and PLR.  
4.5.5.    Residuals and correlation exercises 
The normal probability plot of the residuals for final setting time is linear (Fig. 23), 
indicating that the errors are distributed normally. The match between the predicted and 





























Fig. 24.  The correlation plot of the final setting time results for a calcium phosphate 









4.5.6.   Optimization exercise 
To obtain the optimum combination for obtaining a final setting time of 15 min [54], 
response surface, contour, and desirability plots were developed for the proposed model 
that contained only the significant coefficients (Eq. (4)). A contour plot is produced to 
display the regions of the optimal factor settings. Either the response surface plot or the 
contour plot can be used to predict the response (target final setting time of 15 min) for 
any zone of the experimental domain. As shown on the surface response plot (Fig. 25A), 
the desired optimum is a target value rather than showing the maximum achievable 
setting time. After identifying the stationary point in a contour plot, it has to be 
determined if it is the maximum, minimum, target, or saddle point. An analysis of the 
response surface and contour plots   (Figs. 25A and B) found that the indicated target 
point (15 min) has high desirability compared to other location with same target setting 
time in minutes (Fig. 25C). The corresponding parameters that yielded this 15 min target 
final setting time value desired were PC = 3.96 wt/wt% and PLR = 2.86 g mL
-1
.  
However, there are 33 possible numerical RSM solutions that gives the target final 
setting time of 15 min and, thus, multiple solutions are expected where the contour plot 
































Fig 25. The response surface plot (A), contour plot (B), and desirability plot (C) for the 













4.6.  Case Study #6:   Compressive strength of a calcium phosphate cement 
4.6.1.   Experimental details 
The powder constituents of the cement were CaCO3, DCPA, and TCP, while the 
liquid was an aqueous solution of 4 wt/wt% poly(acrylic acid) (PAA) and Na2HPO4 
(SPC). The powder and liquid were mixed, with  a spatula, in  a glass dish, until a paste 
was obtained. 
The inside surface of each of the six cells in a cylindrical steel mold, with each cell 
nominal diameter (D) and height of 6 mm and 12 mm, respectively, was packed with a 
thin layer of a release agent was spread. The cement powder and liquid were mixed until 
a paste was obtained, after which it was injected into the cells. To eliminate large air 
bubbles in the paste, the mold was covered with a solid steel plate and then the whole 
assembly was put in a mechanical press, under a load of 70 kN, for 1 h. After 
disassembly, the cement specimens were immersed in a container filled with phosphate 
buffered saline. A lid was placed on the container and tightened, after which the container 
was placed in an incubator, set at 37
o 
C. After 1 day, the mold was removed from the 
container, the specimens punched out of the mold, and then lightly sanded. The 
specimens were then placed in distilled water for 7 d before being tested. In the test, a 
specimen was compressed in a servohydraulically-actuated universal materials testing 
machine, operated at a crosshead displacement rate of 0.5 mm min
-1
, until its height was 
reduced to about 10% of its initial value or the specimen fractured, whichever occurred 
first. From the load-versus-crosshead displacement record, compressive strength (UCS) 
was calculated thus   
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      UCS  = (4Fmax)/(D
2
),   (31) 
 
where Fmax is the peak load.  
Each test was run in triplicate. The results are given in Table 26.   
 
Table 26 
Compressive strength (UCS) of a calcium phosphate cement  
  Na2HPO4 content         PLR                                   UCS 
  (wt/wt%)          (g mL
-1
)             (MPa) 
         0               2.5              24 ± 2 
         0               3.0                        31 ± 3 
         0               3.5              42 ± 5 
         2               2.5              20 ± 3 
         2               3.0              27 ± 4 
         2               3.5              34 ± 6 
         4               2.5              18 ± 1 
         4               3.0              24 ± 3 





4.6.2.  Design matrix 
Two factors (explanatory variables) were considered for their influence on UCS; 
namely, Na2HPO4 content (SPC) and powder-to-liquid ratio (PLR).  For each factor, 
three values were used; thus, there were 27 data points.  
For the RSM work (Design Expert
®
, Version 8), therefore, it was appropriate to use 
the two-factors, three-levels, central composite design matrix face centered option (CCD 
option). The values of the factors used and the corresponding level for each factor are 
given in Table 27 while, in Table 28, the 27 data points are presented both as coded 
values and as raw values.  
  
Table 27  
Factors and their levels: compressive strength of a calcium phosphate cement 
Factor Unit 
Coded levels 
-1 0 +1 
















Design matrix and experimental results: compressive strength of a calcium phosphate 
cement  
      Cement  
Coded values   Raw values 
 UCS   
(MPa) SPC PLR 
       SPC 
   (wt/wt%) 
          PLR 
        (g mL
-1
) 
A -1 -1 0.00 2.50 22 
 -1 -1 0.00 2.50 24 
 -1 -1 0.00 2.50 26 
B -1 0 0.00 3.00 28 
 -1 0 0.00 3.00 31 
 -1 0 0.00 3.00 34 
C -1 +1 0.00 3.50 37 
 -1 +1 0.00 3.50 42 
 -1 +1 0.00 3.50 47 
D 0 -1 2.00 2.50 17 
 0 -1 2.00 2.50 20 
 0 -1 2.00 2.50 23 
E 0 0 2.00 3.00 23 
 0 0 2.00 3.00 27 
 0 0 2.00 3.00 31 
F 0 +1 2.00 3.50 28 
 0 +1 2.00 3.50 34 
 0 +1 2.00 3.50 40 
J +1 -1 4.00 2.50 17 
 +1 -1 4.00 2.50 18 
 +1 -1 4.00 2.50 19 
K +1 0 4.00 3.00 21 
 +1 0 4.00 3.00 24 
 +1 0 4.00 3.00 27 
L +1 +1 4.00 3.50 29 
 +1 +1 4.00 3.50 33 




4.6.3.   Empirical relationship and regression analysis 
The second-order polynomial (regression) equation used to represent the response 
surface (UCS) is given by 
 
             UCS = bo + ∑ bi Xi +∑ bij Xi Xj +∑ bii Xi
2
,                              (32)
  
 
where Xi and Xj are the two factors. 
Thus, the selected polynomial could be expressed as 
 
               UCS = bo + b1 (SPC)+ b2 (PLR) + b12 (SPC)(PLR)  +  b11 (SPC)
2  








where bo is the average of the responses; b1 and b2 are the regression coefficients that 
characterize the direct effects of the factors; b12 is the regression coefficient that 
characterizes the interaction effect of the factors; and b11 and b22 are the regression 
coefficients that characterize the quadratic effects of the factors.  
With the computed values of the coefficients, it is found the cubic and above models 
were aliased. In experimental design, when two interactions, or a main effect and an 
interaction, share the same column, and so cannot be individually analyzed, then their 
effects are termed “aliased”. Linear model is suggested to best fit the model. The two 
factors interaction 2FI model and the quadratic models have non-significant terms and 
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could not best fit the model. Hence, the linear model is used in RSM and Eq. (33) 
becomes 
 
UCS = -15.22 - 1.83(SPC) + 15.67(PLR)    (34)
 
                                                                                                                                                                      
 
4.6.4.     Adequacy of regression model 
Analysis of variance (ANOVA) of the regression model was performed and the 
results (Table 29) were used to examine the adequacy of the model. The desired level of 
confidence was considered to be adequate provided that 1) the calculated value of the F 
ratio of the model developed did not exceed the standard tabulated value of the F ratio 
and 2) the calculated value of the coefficient of determination (R
2
) of the developed 
relationship exceeded the standard tabulated value of the R
2
 for a desired level of 








Table 29    






df  Mean 
square  
F value  p-value  
Prob>F 
 
Model  1346.50 2 673.25 55.304 < 0.0001 significant 
SPC  242.00 1 242.00 19.879 0.0002  
PLR  1104.50 1 1104.50 90.729 < 0.0001  
Residual  292.17 24 12.17    
Lack of fit 42.17 6 7.03 0.506 0.7958 not significant 
Pure error 250.00 18 13.89    
Cor total  1638.67 26     
Std dev 3.49 R
2
 0.8217    
Mean 28.11 Adj R
2
 0.8068    
COV (%) 12.41 Pred R
2
 0.7748    
  Adeq 
precision 
19.776     
 
The model F-value of 55.304 implies the model is significant because there is only a 
0.01% chance that a model F-value this large could occur due to noise. The goodness of 
fit of the model is indicated by the coefficient of determination (R
2
), which was found to 
be 0.8217, which implies that 82.17% of the experimental data were predicted by the 
model. The adjusted R
2
, 0.8068, was high enough to confirm the high significance of the 
model. The predicted R
2
 is 0.7748, which means that the model could explain 77% of the 
variability in predicting new UCS observations. The parameter, Adeq precision, is a 
measure of the signal-to-noise ratio, with a value > 4 considered desirable. In this case 
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study, the ratio was 19.776, which indicated an adequate signal. The coefficient of 
variation (COV), 12.41%, is more than 10% but still considered low enough to indicate 
that the deviations between the experimental and the predicted UCS values are small. All 
of the aforementioned ANOVA results show that the model (Eq. (34)) was adequate and, 
thus, may be used to navigate the design space.  
For a model term, a value of Prob>F less than 0.0500 indicates that it is significant. 
Thus, in this case study, SPC and PLR are the only significant model terms and there is 
no interaction terms or square terms. In this case, the final model Equation is  
 
                           UCS = -15.22 - 1.83(SPC) + 15.67(PLR)                                            (35) 
 
For a given response, the contributions of factors can be ranked from their respective 
F ratio values provided the degrees of freedom are same for all the input parameters. The 
larger the F ratio the higher is the significance. From the F ratio values (Table 3), it is 
seen that PLR exerts the greatest influence on UCS.  
4.6.5.    Residuals and correlation exercises 
The normal probability plot of the residuals for UCS is linear (Fig. 26), indicating that 
the errors are distributed normally. The match between the predicated and the 

























4.6.6.   Optimization exercise 
To obtain the optimum combination for maximizing UCS of the cement, response 
surface, contour, and desirability plots were developed for the proposed model that 
contained only the significant coefficients (Eq. (35)). A contour plot is produced to 
display the regions of the optimal factor settings. Either the response surface plot or the 
contour plot can be used to predict the response (UCS value) for any zone of the 
experimental domain. The left-hand tip of the response plot (Fig. 28A) shows the 
maximum achievable UCS. After identifying the stationary point in a contour plot, it has 
to be determined if it is the maximum, minimum, or saddle point. An analysis of the 
response surface and contour plots (Figs. 28A and B), the maximum achievable UCS is 
39.11 MPa. The corresponding parameters that yielded this maximum value (desirability 






































Fig. 28. The response surface plot (A), contour plot (B), and desirability plot (C) for the 
influence of di-sodium phosphate content and powder-to-liquid ratio on the compressive 








CONCLUSIONS AND RECOMMENDATIONS 
Based on the results obtained in this study, using the response surface methodology 
(RSM), the following are the main conclusions: 
(1) While interaction effects are significant for injectability and final setting time of a 
calcium phosphate cement, they are not significant for degradability, maximum exotherm 
temperature, and residual monomer content of a PMMA bone cement, and compressive 
strength of a calcium phosphate cement.  
(2)  For a given cement property, its optimum value was obtained together with the 
values of the experimental variables to produce this result. Thus, in the case of a PMMA 
bone cement, 1) the minimum exotherm temperature (48
o 
C) could be attained using a 
cement having barium sulfate and quaternary amine commoner contents of 26.5 wt/wt% 
and 19.8 wt/wt%, respectively; 2) the minimum residual monomer content 7 days after 
the cement was cured (1.81%) could be attained using a cement having barium sulfate 
and quaternary amine commoner contents of 20.3 wt/wt% and 0, respectively; and 3) the 
optimum degradability (41%) could be attained using a cement having a PMMA bead, 
bioactive glass particles, and chitosan particles contents of 51, 37, and 12 wt/wt%, 
respectively. In the case of a calcium phosphate bone cement, 1) the optimum 
injectability (98%) could be attained using a cement having a polyethylene glycol (PEG) 
content of 20 wt/wt% and mixed using a powder-to-liquid ratio (PLR) of 2.0 g mL
-1
; 2) a 
final mixing time of 15 min could be attained using a cement having a PEG content of 
3.96 wt/wt% and mixed using a PLR of 2.86 g mL
-1
. In addition, multiple numerical 
solutions exist for this target time; and 3) the optimum 7-day compressive strength       
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(39 MPa) could be attained by adding no Na2HPO4 to the poly(acrylic acid) for the 
cement liquid and mix the powder and the liquid using PLR of 3.5 g mL
-1
.    
(3) In the case of a calcium phosphate cement (CPC), PLR exerts significant direct 
effects on each of the three cement properties that were investigated (injectability, final 
setting time, and 7-day compressive strength). Clinicians should keep this finding mind 
when preparing a CPC for use in vertebroplasty and balloon kyphoplasty. 
The following recommendations are made for future study: 
(1) For each property considered in this study, it should be determined experimentally 
using the computed values of the explanatory variables. For example, determine Tmax of 
the PMMA bone cement having barium sulfate and quaternary amine comonomer 
contents of 26.5 wt/wt% and 19.8 wt/wt%, respectively, and compare the result to that 
computed using RSM (that is, 48
o
 C). Another example is final setting time F of the CPC, 
where multiple numerical solutions found can also be verified experimentally using the 
computed values of the explanatory variables.  
(2)  Experimental determinations of the cement properties should be conducted using 
a host of variables. For example, in the case of the CPC, 7-day compressive strength 
(UCS) should be determined for a cement in which the variables are PEG content, 
nanosized titania particles, citric acid content, disodium pamidronate content, and PLR. 
After that, RSM should be used to analyze the experimental results in order to compute 
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